{
  "@type" : "TEMPLATE",
  "uid" : "324c708b-0b93-4b73-9e06-18e900ac6d79",
  "description" : {
    "@type" : "RESOURCE_DESCRIPTION",
    "originalAuthor" : {
      "date" : "2024-03-22"
    },
    "otherContributors" : [ ],
    "lifecycleState" : {
      "codeString" : "unmanaged"
    },
    "ipAcknowledgements" : { },
    "references" : { },
    "conversionDetails" : { },
    "otherDetails" : {
      "licence" : "",
      "custodian_organisation" : "",
      "original_namespace" : "",
      "original_publisher" : "",
      "custodian_namespace" : "",
      "sem_ver" : "7.0.0",
      "build_uid" : "",
      "MD5-CAM-1.0.1" : "a82f26df9313ee57308792d43dd594d5",
      "PARENT:MD5-CAM-1.0.1" : "005501C1FA493A4838F5F1121F2870EC"
    },
    "details" : {
      "de" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "de"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "sv" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "sv"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "fi" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "fi"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "ko" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "ko"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "pt-br" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "pt-br"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "en" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "en"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "ar-sy" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "ar-sy"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "it" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "it"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "zh" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "zh"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "nb" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "nb"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "es-ar" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "es-ar"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "sl" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "sl"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      },
      "nl" : {
        "@type" : "RESOURCE_DESCRIPTION_ITEM",
        "language" : {
          "terminologyId" : {
            "value" : "ISO_639-1"
          },
          "codeString" : "nl"
        },
        "keywords" : [ ],
        "originalResourceUri" : { },
        "otherDetails" : { }
      }
    }
  },
  "parentArchetypeId" : "openEHR-EHR-COMPOSITION.report.v1",
  "differential" : false,
  "archetypeId" : {
    "@type" : "ARCHETYPE_HRID",
    "value" : "openEHR-EHR-COMPOSITION.t_report.v1"
  },
  "definition" : {
    "@type" : "C_COMPLEX_OBJECT",
    "rmTypeName" : "COMPOSITION",
    "occurrences" : "1..1",
    "nodeId" : "at0000.1",
    "attributes" : [ {
      "@type" : "C_ATTRIBUTE",
      "rmAttributeName" : "category",
      "existence" : "1..1",
      "children" : [ {
        "@type" : "C_COMPLEX_OBJECT",
        "rmTypeName" : "DV_CODED_TEXT",
        "occurrences" : "1..1",
        "attributes" : [ {
          "@type" : "C_ATTRIBUTE",
          "rmAttributeName" : "defining_code",
          "existence" : "1..1",
          "children" : [ {
            "@type" : "C_TERMINOLOGY_CODE",
            "rmTypeName" : "CODE_PHRASE",
            "occurrences" : "1..1",
            "terminologyId" : {
              "value" : "openehr"
            },
            "constraint" : [ "433" ]
          } ]
        } ],
        "attributeTuples" : [ ]
      } ]
    }, {
      "@type" : "C_ATTRIBUTE",
      "rmAttributeName" : "context",
      "existence" : "0..1",
      "children" : [ {
        "@type" : "C_COMPLEX_OBJECT",
        "rmTypeName" : "EVENT_CONTEXT",
        "occurrences" : "1..1",
        "attributes" : [ {
          "@type" : "C_ATTRIBUTE",
          "rmAttributeName" : "other_context",
          "existence" : "0..1",
          "children" : [ {
            "@type" : "C_COMPLEX_OBJECT",
            "rmTypeName" : "ITEM_TREE",
            "occurrences" : "1..1",
            "nodeId" : "at0001",
            "attributes" : [ {
              "@type" : "C_ATTRIBUTE",
              "rmAttributeName" : "items",
              "existence" : "0..1",
              "cardinality" : {
                "@type" : "CARDINALITY",
                "interval" : "0..*",
                "ordered" : false,
                "unique" : false
              },
              "children" : [ {
                "@type" : "C_COMPLEX_OBJECT",
                "rmTypeName" : "ELEMENT",
                "occurrences" : "0..1",
                "nodeId" : "at0002",
                "attributes" : [ {
                  "@type" : "C_ATTRIBUTE",
                  "rmAttributeName" : "value",
                  "existence" : "0..1",
                  "children" : [ {
                    "@type" : "C_COMPLEX_OBJECT",
                    "rmTypeName" : "DV_TEXT",
                    "occurrences" : "1..1",
                    "attributes" : [ ],
                    "attributeTuples" : [ ]
                  } ]
                } ],
                "attributeTuples" : [ ]
              }, {
                "@type" : "C_COMPLEX_OBJECT",
                "rmTypeName" : "ELEMENT",
                "occurrences" : "0..1",
                "nodeId" : "at0005",
                "attributes" : [ {
                  "@type" : "C_ATTRIBUTE",
                  "rmAttributeName" : "value",
                  "existence" : "0..1",
                  "children" : [ {
                    "@type" : "C_COMPLEX_OBJECT",
                    "rmTypeName" : "DV_TEXT",
                    "occurrences" : "1..1",
                    "attributes" : [ ],
                    "attributeTuples" : [ ]
                  } ]
                } ],
                "attributeTuples" : [ ]
              }, {
                "@type" : "ARCHETYPE_SLOT",
                "rmTypeName" : "CLUSTER",
                "occurrences" : "0..*",
                "nodeId" : "at0006",
                "includes" : [ {
                  "@type" : "ASSERTION",
                  "stringExpression" : "archetype_id/value matches {/.*/}",
                  "expression" : {
                    "@type" : "BINARY_OPERATOR",
                    "type" : "BOOLEAN",
                    "operator" : "matches",
                    "leftOperand" : {
                      "@type" : "MODEL_REFERENCE",
                      "type" : "STRING",
                      "precedenceOverriden" : false,
                      "referenceType" : "Attribute",
                      "path" : "archetype_id/value"
                    },
                    "rightOperand" : {
                      "@type" : "CONSTRAINT",
                      "type" : "STRING",
                      "precedenceOverriden" : false,
                      "referenceType" : "Constraint",
                      "item" : {
                        "@type" : "C_STRING",
                        "constraint" : [ "/.*/" ]
                      }
                    },
                    "precedenceOverriden" : false
                  },
                  "variables" : [ ]
                } ],
                "excludes" : [ ],
                "closed" : false
              }, {
                "@type" : "C_ARCHETYPE_ROOT",
                "rmTypeName" : "CLUSTER",
                "occurrences" : "0..1",
                "nodeId" : "at0006.1",
                "attributes" : [ ],
                "attributeTuples" : [ ],
                "archetypeRef" : "openEHR-EHR-CLUSTER.ovl-care_journey_metadata-001.v0",
                "referenceType" : "archetypeOverlay"
              } ]
            } ],
            "attributeTuples" : [ ]
          } ]
        } ],
        "attributeTuples" : [ ]
      } ]
    }, {
      "@type" : "C_ATTRIBUTE",
      "rmAttributeName" : "content",
      "existence" : "0..1",
      "cardinality" : {
        "@type" : "CARDINALITY",
        "interval" : "1..*",
        "ordered" : false,
        "unique" : false
      },
      "children" : [ {
        "@type" : "C_ARCHETYPE_ROOT",
        "rmTypeName" : "EVALUATION",
        "occurrences" : "0..1",
        "nodeId" : "at0.12",
        "attributes" : [ ],
        "attributeTuples" : [ ],
        "archetypeRef" : "openEHR-EHR-EVALUATION.ovl-adverse_reaction_risk-001.v2",
        "referenceType" : "archetypeOverlay"
      }, {
        "@type" : "C_ARCHETYPE_ROOT",
        "rmTypeName" : "EVALUATION",
        "occurrences" : "0..1",
        "nodeId" : "at0.16",
        "attributes" : [ ],
        "attributeTuples" : [ ],
        "archetypeRef" : "openEHR-EHR-EVALUATION.ovl-precaution-001.v1",
        "referenceType" : "archetypeOverlay"
      } ]
    } ],
    "attributeTuples" : [ ]
  },
  "terminology" : {
    "@type" : "ARCHETYPE_TERMINOLOGY",
    "conceptCode" : "at0000",
    "termDefinitions" : {
      "ar-sy" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "وثيقة لتوصيل المعلومات للآخرين, عادة كاستجابة لطلب من طرف آخر."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "تقرير",
          "description" : "وثيقة لتوصيل المعلومات للآخرين, عادة كاستجابة لطلب من طرف آخر."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "*Tree(en)",
          "description" : "*@ internal @(en)"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "العنصر التعريفي الفريد للتقرير",
          "description" : "معلومات التعريف حول التقرير"
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "الحالة",
          "description" : "حالة التقرير بشكل كلي. و لا تمثل هذه الحالة جزءا من التقرير و إنما جميعه ككل."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "*Additional information required to capture local context or to align with other reference models/formalisms.(en)",
          "comment" : "* e.g. Local hospital departmental infomation or additional metadata to align with FHIR or CIMI equivalents.(en)"
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "*Additional information required to capture local context or to align with other reference models/formalisms.(en)",
          "comment" : "* e.g. Local hospital departmental infomation or additional metadata to align with FHIR or CIMI equivalents.(en)"
        }
      },
      "sl" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "*Document to communicate information to others, commonly in response to a request from another party.(en)"
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Poročilo",
          "description" : "*Document to communicate information to others, commonly in response to a request from another party.(en)"
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "*@ internal @(en)"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "ID Poročila",
          "description" : "*Identification information about the report.(en)"
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "*The status of the entire report. Note: This is not the status of any of the report components.(en)"
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "*Additional information required to capture local context or to align with other reference models/formalisms.(en)",
          "comment" : "* e.g. Local hospital departmental infomation or additional metadata to align with FHIR or CIMI equivalents.(en)"
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "*Additional information required to capture local context or to align with other reference models/formalisms.(en)",
          "comment" : "* e.g. Local hospital departmental infomation or additional metadata to align with FHIR or CIMI equivalents.(en)"
        }
      },
      "en" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "Allergien",
          "description" : "Document to communicate information to others, commonly in response to a request from another party."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Report",
          "description" : "Document to communicate information to others, commonly in response to a request from another party."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Report ID",
          "description" : "Identification information about the report."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "The status of the entire report. Note: This is not the status of any of the report components."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Extension",
          "description" : "Additional information required to capture local context or to align with other reference models/formalisms.",
          "comment" : "For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Extension",
          "description" : "Additional information required to capture local context or to align with other reference models/formalisms.",
          "comment" : "For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents."
        }
      },
      "es-ar" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Documento para comunicar información a otros, comunmente en respuesta a la solicitud de un tercero."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Informe",
          "description" : "Documento para comunicar información a otros, comunmente en respuesta a la solicitud de un tercero."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "ID del informe",
          "description" : "Información para la identificación del informe."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Estado",
          "description" : "El estado del informe como un todo. Nota: no se refiere al estado de alguno de los componentes del informe."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "*Additional information required to capture local context or to align with other reference models/formalisms.(en)",
          "comment" : "* e.g. Local hospital departmental infomation or additional metadata to align with FHIR or CIMI equivalents.(en)"
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "*Additional information required to capture local context or to align with other reference models/formalisms.(en)",
          "comment" : "* e.g. Local hospital departmental infomation or additional metadata to align with FHIR or CIMI equivalents.(en)"
        }
      },
      "pt-br" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Documento para comunicar informações a outros, comumente em resposta a uma solicitação de terceiros."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Relatório",
          "description" : "Documento para comunicar informações a outros, comumente em resposta a uma solicitação de terceiros."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Identificador do relatório",
          "description" : "Informação de identificação sobre o relatório."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Estado",
          "description" : "O estado de todo o relatório. Nota: este não é o estado de qualquer dos componentes do relatório."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Extensão",
          "description" : "Informação adicional requerida para capturar o contexto local ou para alinhar a outros modelos de referência/formalismos.",
          "comment" : "Por exemplo: requisitos de informações locais ou metadados para alinhar com equivalentes do FHIR or CIMI."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Extensão",
          "description" : "Informação adicional requerida para capturar o contexto local ou para alinhar a outros modelos de referência/formalismos.",
          "comment" : "Por exemplo: requisitos de informações locais ou metadados para alinhar com equivalentes do FHIR or CIMI."
        }
      },
      "nb" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Dokument som brukes for å kommunisere informasjon til andre, ofte som svar på en forespørsel."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Rapport",
          "description" : "Dokument som brukes for å kommunisere informasjon til andre, ofte som svar på en forespørsel."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Rapport ID",
          "description" : "Informasjon som identifiserer rapporten."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "Status for hele rapporten. Merk: Dette er ikke statusen for noen av enkeltkomponentene i rapporten."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Tilleggsinformasjon",
          "description" : "Ytterligere informasjon som trengs for å kunne registrere lokalt definert innhold eller for å tilpasse til andre referansemodeller/formalismer.",
          "comment" : "For eksempel lokale informasjonsbehov eller ytterligere metadata for å kunne tilpasse til tilsvarende konsepter i FHIR eller CIMI."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Tilleggsinformasjon",
          "description" : "Ytterligere informasjon som trengs for å kunne registrere lokalt definert innhold eller for å tilpasse til andre referansemodeller/formalismer.",
          "comment" : "For eksempel lokale informasjonsbehov eller ytterligere metadata for å kunne tilpasse til tilsvarende konsepter i FHIR eller CIMI."
        }
      },
      "de" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "Patientenverfügung",
          "description" : "Ein Dokument zur Übermittlung von Informationen an andere, meist als Antwort auf eine Anfrage."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Bericht",
          "description" : "Ein Dokument zur Übermittlung von Informationen an andere, meist als Antwort auf eine Anfrage."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Bericht ID",
          "description" : "Identifizierungsmerkmal des Berichts."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "Der Status des gesamten Berichts. Hinweis: Dies ist nicht der Status einer Berichtskomponente."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Erweiterung",
          "description" : "Zusätzliche Informationen zur Erfassung lokaler Inhalte oder Anpassung an andere Referenzmodelle/Formalismen.",
          "comment" : "Zum Beispiel: lokaler Informationsbedarf oder zusätzliche Metadaten zur Anpassung an FHIR-Ressourcen oder CIMI-Modelle."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Erweiterung",
          "description" : "Zusätzliche Informationen zur Erfassung lokaler Inhalte oder Anpassung an andere Referenzmodelle/Formalismen.",
          "comment" : "Zum Beispiel: lokaler Informationsbedarf oder zusätzliche Metadaten zur Anpassung an FHIR-Ressourcen oder CIMI-Modelle."
        }
      },
      "ko" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "일반적으로 다른 상대의 요청에 대한 응답으로, 다른 사람들과 정보를 통신하는 문서."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "*Report(en)",
          "description" : "일반적으로 다른 상대의 요청에 대한 응답으로, 다른 사람들과 정보를 통신하는 문서."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "*Report ID(en)",
          "description" : "리포트에 대한 식별 정보."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "*Status(en)",
          "description" : "전체 리포트의 상태. 주의: 이것은 리포트 컴포넌트들 중 어떤 부분의 상태가 아님."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "로컬 컨텍스트를 획득하는데 필요하거나 다른 참조 모델/표현과 조정에 필요한 추가 정보",
          "comment" : "예: 로컬 정보 요구사항 또는 FHIR나 CIMI의 동등한 것들과 조정하는 추가 메타데이터"
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "*Extension(en)",
          "description" : "로컬 컨텍스트를 획득하는데 필요하거나 다른 참조 모델/표현과 조정에 필요한 추가 정보",
          "comment" : "예: 로컬 정보 요구사항 또는 FHIR나 CIMI의 동등한 것들과 조정하는 추가 메타데이터"
        }
      },
      "fi" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Asiakirja tiedon välittämiseksi muille, vastauksena yleensä toisen osapuolen pyyntöön."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Raportti",
          "description" : "Asiakirja tiedon välittämiseksi muille, vastauksena yleensä toisen osapuolen pyyntöön."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Raportti ID",
          "description" : "Raportin tunnistetiedot"
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "Koko raportin tila. Huomaa: Tämä ei ole minkään raporttiosien tila."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Laajennus",
          "description" : "Tarvitaan lisätietoja paikallisen tilanteen mallintamiseksi tai yhdenmukaistamiseksi muiden vertailumallien / muodollisuuksien kanssa. \r\n",
          "comment" : "Esimerkiksi: paikalliset tietovaatimukset tai ylimääräiset metatiedot FHIR- tai CIMI-vastaavien mukaisiksi."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Laajennus",
          "description" : "Tarvitaan lisätietoja paikallisen tilanteen mallintamiseksi tai yhdenmukaistamiseksi muiden vertailumallien / muodollisuuksien kanssa. \r\n",
          "comment" : "Esimerkiksi: paikalliset tietovaatimukset tai ylimääräiset metatiedot FHIR- tai CIMI-vastaavien mukaisiksi."
        }
      },
      "it" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Documento per comunicare informazioni ad altri, comunemente in risposta ad una richiesta di un altro soggetto."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Rapporto",
          "description" : "Documento per comunicare informazioni ad altri, comunemente in risposta ad una richiesta di un altro soggetto."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "ID del rapporto",
          "description" : "Informazioni di identificazione del rapporto"
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Stato",
          "description" : "Lo stato dell'intero rapporto. Nota: Questo non è lo stato di alcuna delle componenti del rapporto."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Estensione",
          "description" : "Informazioni aggiuntive necessarie per catturare il contesto locale o per allinearsi con altri modelli/formalismi di riferimento.",
          "comment" : "Per esempio: requisiti informativi locali o metadati aggiuntivi per allinearsi con gli equivalenti FHIR o CIMI."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Estensione",
          "description" : "Informazioni aggiuntive necessarie per catturare il contesto locale o per allinearsi con altri modelli/formalismi di riferimento.",
          "comment" : "Per esempio: requisiti informativi locali o metadati aggiuntivi per allinearsi con gli equivalenti FHIR o CIMI."
        }
      },
      "nl" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Document om informatie met anderen te communiceren, vaak op verzoek van een andere partij."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Rapportage",
          "description" : "Document om informatie met anderen te communiceren, vaak op verzoek van een andere partij."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Rapportage ID",
          "description" : "Identificerende informatie over deze rapportage."
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "De status van de rapportage. Let op, dit is niet de status van een van de onderdelen van de rapportage."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Uitbreiding",
          "description" : "Extra informatie nodig om de context te beschrijven of te voldoen aan andere modellen of formalismen.",
          "comment" : "Bijvoorbeeld: lokale informatievereisten of aanvullende metadata om overeen te komen met FHIR- of CIMI-equivalenten."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Uitbreiding",
          "description" : "Extra informatie nodig om de context te beschrijven of te voldoen aan andere modellen of formalismen.",
          "comment" : "Bijvoorbeeld: lokale informatievereisten of aanvullende metadata om overeen te komen met FHIR- of CIMI-equivalenten."
        }
      },
      "sv" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "Dokument för att förmedla information till andra, vanligen som svar på en begäran från en annan part."
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "Rapport",
          "description" : "Dokument för att förmedla information till andra, vanligen som svar på en begäran från en annan part."
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "Rapport-id",
          "description" : "Information som identifierar rapporten.\r\n"
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "Status",
          "description" : "Status för hela rapporten. Observera att detta inte är status för någon av rapportkomponenterna."
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Tilläggsinformation",
          "description" : "Plats för tilläggsinformation som krävs för lokala anpassningar eller anpassning till andra referensmodeller eller formella krav.",
          "comment" : "Exempelvis lokala informationskrav eller metadata för anpassning till FHIR- eller CIMI-motsvarigheter."
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "Tilläggsinformation",
          "description" : "Plats för tilläggsinformation som krävs för lokala anpassningar eller anpassning till andra referensmodeller eller formella krav.",
          "comment" : "Exempelvis lokala informationskrav eller metadata för anpassning till FHIR- eller CIMI-motsvarigheter."
        }
      },
      "zh" : {
        "at0000.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000.1",
          "text" : "RSO_color",
          "description" : "用于交流信息的文件，通常是为了响应某一方的请求"
        },
        "at0000" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0000",
          "text" : "报告",
          "description" : "用于交流信息的文件，通常是为了响应某一方的请求"
        },
        "at0001" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0001",
          "text" : "Tree",
          "description" : "@ internal @"
        },
        "at0002" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0002",
          "text" : "报告ID",
          "description" : "关于这份报告的标识信息。"
        },
        "at0005" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0005",
          "text" : "状态",
          "description" : "整份报告的状态。注意：这不是指报告的任何一个组成部分的状态"
        },
        "at0006" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "扩展",
          "description" : "用于捕获本地的上下文或与其他参考模型/形式保持一致所需的其他信息。",
          "comment" : "比如：本地的信息需求或是为了与FHIR或CIMI保持一致的其他元数据。"
        },
        "at0006.1" : {
          "@type" : "ARCHETYPE_TERM",
          "code" : "at0006",
          "text" : "扩展",
          "description" : "用于捕获本地的上下文或与其他参考模型/形式保持一致所需的其他信息。",
          "comment" : "比如：本地的信息需求或是为了与FHIR或CIMI保持一致的其他元数据。"
        }
      }
    },
    "termBindings" : { },
    "terminologyExtracts" : { },
    "valueSets" : { }
  },
  "adlVersion" : "1.4",
  "buildUid" : "b057d0e0-45b9-3d97-ab87-3004b7f6d386",
  "rmName" : "openehr",
  "rmRelease" : "1.1.0",
  "generated" : true,
  "templateId" : "Allergien",
  "otherMetaData" : { },
  "templateOverlays" : [ {
    "@type" : "TEMPLATE_OVERLAY",
    "uid" : "488324de-e79f-4ded-abb2-0a669569908a",
    "description" : {
      "@type" : "RESOURCE_DESCRIPTION",
      "originalAuthor" : { },
      "otherContributors" : [ ],
      "ipAcknowledgements" : { },
      "references" : { },
      "conversionDetails" : { },
      "otherDetails" : {
        "PARENT:MD5-CAM-1.0.1" : "375F6CD7464C065CF56FC7D2EEC836FD"
      },
      "details" : {
        "de" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "de"
          },
          "keywords" : [ ],
          "copyright" : "© openEHR Foundation",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "en" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "en"
          },
          "keywords" : [ ],
          "originalResourceUri" : { },
          "otherDetails" : { }
        }
      }
    },
    "parentArchetypeId" : "openEHR-EHR-CLUSTER.care_journey_metadata.v0",
    "differential" : false,
    "archetypeId" : {
      "@type" : "ARCHETYPE_HRID",
      "value" : "openEHR-EHR-CLUSTER.ovl-care_journey_metadata-001.v0"
    },
    "definition" : {
      "@type" : "C_COMPLEX_OBJECT",
      "rmTypeName" : "CLUSTER",
      "occurrences" : "1..1",
      "nodeId" : "at0000.1",
      "attributes" : [ {
        "@type" : "C_ATTRIBUTE",
        "rmAttributeName" : "items",
        "existence" : "1..1",
        "cardinality" : {
          "@type" : "CARDINALITY",
          "interval" : "1..*",
          "ordered" : false,
          "unique" : false
        },
        "children" : [ {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ELEMENT",
          "occurrences" : "0..1",
          "nodeId" : "at0001",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "value",
            "existence" : "0..1",
            "children" : [ {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "DV_TEXT",
              "occurrences" : "1..1",
              "attributes" : [ ],
              "attributeTuples" : [ ]
            } ]
          } ],
          "attributeTuples" : [ ]
        }, {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ELEMENT",
          "occurrences" : "0..1",
          "nodeId" : "at0002.1",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "value",
            "existence" : "0..1",
            "children" : [ {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "DV_IDENTIFIER",
              "occurrences" : "1..1",
              "defaultValue" : {
                "@type" : "DV_IDENTIFIER"
              },
              "attributes" : [ ],
              "attributeTuples" : [ ]
            } ]
          } ],
          "attributeTuples" : [ ]
        }, {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ELEMENT",
          "occurrences" : "0..1",
          "nodeId" : "at0003.1",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "value",
            "existence" : "0..1",
            "children" : [ {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "DV_IDENTIFIER",
              "occurrences" : "1..1",
              "defaultValue" : {
                "@type" : "DV_IDENTIFIER"
              },
              "attributes" : [ ],
              "attributeTuples" : [ ]
            } ]
          } ],
          "attributeTuples" : [ ]
        } ]
      } ],
      "attributeTuples" : [ ]
    },
    "terminology" : {
      "@type" : "ARCHETYPE_TERMINOLOGY",
      "conceptCode" : "at0000",
      "termDefinitions" : {
        "en" : {
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Care journey metadata",
            "description" : "Tp capture Care plan metadata"
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Care plan name",
            "description" : "The name , preferably coded of the Care plan with which this journey is associated, and against which the composition was updated."
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Care plan identifier",
            "description" : "The identifier , preferably coded, of the Care plan with which this journey is associated, and against which the composition was updated."
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Patient journey identifier",
            "description" : "A patient-journey specific identifier i.e unique to a patient's journey along a specific care pathway."
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Care plan identifier",
            "description" : "The identifier , preferably coded, of the Care plan with which this journey is associated, and against which the composition was updated."
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Patient journey identifier",
            "description" : "A patient-journey specific identifier i.e unique to a patient's journey along a specific care pathway."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Care journey metadata",
            "description" : "Tp capture Care plan metadata"
          }
        },
        "de" : {
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Care journey metadata",
            "description" : "*Tp capture Care plan metadata (en)"
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Care plan name",
            "description" : "*The name , preferably coded of the Care plan with which this journey is associated, and against which the composition was updated. (en)"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Care plan identifier",
            "description" : "*The identifier , preferably coded, of the Care plan with which this journey is associated, and against which the composition was updated. (en)"
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Patient journey identifier",
            "description" : "*A patient-journey specific identifier i.e unique to a patient's journey along a specific care pathway. (en)"
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Care plan identifier",
            "description" : "*The identifier , preferably coded, of the Care plan with which this journey is associated, and against which the composition was updated. (en)"
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Patient journey identifier",
            "description" : "*A patient-journey specific identifier i.e unique to a patient's journey along a specific care pathway. (en)"
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Care journey metadata",
            "description" : "*Tp capture Care plan metadata (en)"
          }
        }
      },
      "termBindings" : { },
      "terminologyExtracts" : { },
      "valueSets" : { }
    },
    "adlVersion" : "1.4",
    "buildUid" : "2ad1bd82-b3b3-4d53-ae06-ea512bf2c181",
    "rmName" : "openehr",
    "rmRelease" : "1.1.0",
    "generated" : true,
    "otherMetaData" : { },
    "originalLanguage" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "en"
    },
    "translations" : [ {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "de"
      },
      "author" : { },
      "otherDetails" : { }
    } ]
  }, {
    "@type" : "TEMPLATE_OVERLAY",
    "uid" : "2c2b1261-191a-4cf3-9539-00ca004e3b81",
    "description" : {
      "@type" : "RESOURCE_DESCRIPTION",
      "originalAuthor" : { },
      "otherContributors" : [ ],
      "ipAcknowledgements" : { },
      "references" : { },
      "conversionDetails" : { },
      "otherDetails" : {
        "PARENT:MD5-CAM-1.0.1" : "19F2BC4F565422749861B468594E50E7"
      },
      "details" : {
        "de" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "de"
          },
          "purpose" : "Zur Aufzeichnung der klinischen Beurteilung der Neigung einer Person, eine unerwünschte Reaktion zu verspüren, wenn sie einem bestimmten Stoff oder einer bestimmten Stoffklasse ausgesetzt oder erneut ausgesetzt wird.",
          "keywords" : [ "Reaktion", "Allergie", "allergisch", "unerwünscht", "Ereignis", "Wirkung", "Empfindlichkeit", "Intoleranz", "Überempfindlichkeit", "Nebenwirkung", "Toxizität", "Arzneimittel", "Lebensmittel", "Agent", "Substanz", "immun", "nicht immun", "chemisch", "Anaphylaxie", "Allergen", "Medikation", "Ergänzung", "Medizin", "Naturarzneimittel", "immunologisch", "nicht immunologisch", "Risiko" ],
          "use" : "Wird verwendet, um eine klinische Bewertung der Neigung zu unerwünschten Reaktionen bei künftiger Exposition gegenüber einem bestimmten Stoff oder einer bestimmten Stoffklasse aufzuzeichnen, einschließlich, aber nicht beschränkt auf Ausgangs- und Hilfsstoffe in Arzneimitteln, biologischen Produkten, Metallsalzen und organischen chemischen Verbindungen.\r\n\r\nDieser Archetyp soll einen einzigen Ort in der Gesundheitsakte bieten, um die Neigung zu allen möglichen Reaktionen, von trivial bis lebensbedrohlich, zu dokumentieren:\r\n- immunvermittelt: Typ I-IV (einschließlich allergischer Reaktionen und Überempfindlichkeiten); oder\r\n- nicht immunvermittelt: einschließlich pseudoallergischer Reaktionen, Nebenwirkungen, Unverträglichkeiten und Arzneimitteltoxizitäten.\r\nIn der klinischen Praxis kann es schwierig sein, zwischen immunvermittelten und nicht immunvermittelten Reaktionen zu unterscheiden. Die Identifizierung der Art der Reaktion ist kein Indikator für die Schwere oder das Risiko einer Schädigung des Patienten.\r\n\r\nWenn eine Neigung identifiziert wird, können Informationen oder Beweise zu einem oder mehreren Reaktionsereignissen mithilfe des Archetyps CLUSTER.adverse_reaction_event im SLOT „Zusammenfassung des Reaktionsereignisses“ aufgezeichnet werden.\r\n\r\nDie Identifizierung der Schwere der Manifestation der Reaktion, die im Archetyp CLUSTER.adverse_reaction_event aufgezeichnet wird, kann Aufschluss über die „Kritikalität“ des Nebenwirkungsrisikos geben. Wenn beispielsweise bei der ersten Exposition gegenüber einer Substanz eine Anaphylaxie auftritt, müsste die „Kritikalität“ auf „hoch“ gesetzt werden, da das Risiko hoch ist, dass die Anaphylaxie bei der zweiten und weiteren Expositionen erneut auftritt.\r\n\r\nDieser Archetyp wurde entwickelt, um die Aufzeichnung von Informationen über eine bestimmte Substanz (Amoxicillin, Austern oder Bienenstichgift) oder alternativ eine Substanzklasse (z. B. Penicilline) zu ermöglichen. Wenn eine Substanzklasse erfasst wird, kann mithilfe des Archetyps CLUSTER.adverse_reaction_event die Identifizierung der genauen Substanz pro Reaktion erfasst werden.\r\n\r\nZur Aufzeichnung von Informationen über das positive Vorliegen des Risikos einer Nebenwirkung:\r\n- zur Unterstützung der direkten klinischen Versorgung einer Person;\r\n- als Teil einer Liste verwalteter Nebenwirkungen oder Allergien/Unverträglichkeiten;\r\n- den Austausch von Informationen über die Neigung und Ereignisse im Zusammenhang mit Nebenwirkungen zu unterstützen;\r\n- um die Meldung von Nebenwirkungen zu informieren; Und\r\n- Unterstützung bei computergestützten wissensbasierten Aktivitäten wie klinischer Entscheidungsunterstützung und Warnungen.\r\n\r\nDas Risiko einer unerwünschten Reaktion oder Manifestation muss immer auf einen auslösenden Stoff oder eine auslösende Stoffklasse schließen lassen. Wenn ein gewisser Grad an Unsicherheit darüber besteht, dass ein bestimmter Stoff die Ursache ist, kann der Grad der Unsicherheit mithilfe des Datenelements „Verifizierungsstatus“ erfasst werden. Wenn mehr als eine mögliche Substanz eine Reaktion/Manifestation verursacht haben könnte, sollte jede Substanz mithilfe einer separaten Instanz dieses Archetyps des Nebenwirkungsrisikos aufgezeichnet werden, wobei der „Verifizierungsstatus“ auf den Anfangsstatus „Unbestätigt“ gesetzt ist, damit die Nebenwirkungsprüfung durchgeführt werden kann in klinischen Systemen aktiviert werden. Wenn sich später herausstellt, dass die Substanz nicht ursächlich ist, kann der „Verifizierungsstatus“ auf „Widerlegt“ geändert werden – beispielsweise nach einem Allergietest.",
          "misuse" : "Nicht zur Aufzeichnung physiologischer Reaktionen auf physikalische Einwirkungen wie Hitze, Kälte, Sonnenlicht, Vibration, körperliche Betätigung, Infektionserreger oder Lebensmittelverunreinigungen geeignet. Verwenden Sie zu diesem Zweck einen bestimmten Archetyp für EVALUATION.problem/diagnosis oder CLUSTER.symptom/sign.\r\n\r\nNicht zur Aufzeichnung unerwünschter Ereignisse, einschließlich Fehlern bei klinischen Prozessen, Interventionen oder Produkten, geeignet. Zum Beispiel: anormaler Gebrauch, falsche Dosierung oder fehlerhafte Verabreichung eines Wirkstoffs oder einer Substanz; falsche Etikettierung; Schäden oder Verletzungen, die durch einen Eingriff oder eine Prozedur verursacht werden; Überdosis/Vergiftung usw. Verwenden Sie für diesen Zweck einen bestimmten Archetyp.\r\n\r\nDarf nicht zur Aufzeichnung einer Nebenwirkung verwendet werden, bei der der Stoff unbekannt ist. Verwenden Sie EVALUATION.problem_diagnosis oder CLUSTER.symptom_sign, um als Teil der Gesundheitsakte aufzuzeichnen, bis eine mögliche Substanz identifiziert wird.\r\n\r\nNicht zur Aufzeichnung von Reaktionen auf Transfusionen von Blutprodukten geeignet. Verwenden Sie zu diesem Zweck einen bestimmten Archetyp.\r\n\r\nDarf nicht für die Aufzeichnung von „Alarmen“ verwendet werden. Verwenden Sie zu diesem Zweck EVALUATION.precaution, EVALUATION.contraindication oder verwandte Archetypen.\r\n\r\nNicht für die Aufzeichnung fehlgeschlagener Therapien geeignet.\r\n\r\nDarf nicht für die explizite Aufzeichnung des Fehlens (oder des negativen Vorliegens) einer Reaktion auf „irgendeine Substanz“ oder auf identifizierte Substanzen verwendet werden, zum Beispiel „Keine bekannten Allergien oder Nebenwirkungen“ oder „Keine bekannten Allergien gegen Penicillin“. Verwenden Sie die Archetypen EVALUATION.exclusion_global oder EVALUATION.exclusion_special, um eine positive Aussage zum Ausschluss von Nebenwirkungen auszudrücken.\r\n\r\nNicht zu verwenden für die explizite Erfassung, dass keine Informationen über den Nebenwirkungsstatus eines Patienten eingeholt werden konnten. Verwenden Sie den Archetyp EVALUATION.absence, um eine positive Aussage zu erfassen, dass Informationen nicht eingeholt werden konnten, beispielsweise wenn ein nicht kooperativer Patient sich weigert, Fragen zu beantworten.",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "sv" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "sv"
          },
          "purpose" : "*To record the clinical assessment of the propensity for an individual to experience an adverse reaction if exposed, or re-exposed, to a specified substance or class of substances. (en)",
          "keywords" : [ "reaktion", "allergi", "allergisk", "ogynnsam", "händelse", "effekt", "känslighet", "intolerans", "överkänslighet", "sidoeffekt", "giftighet", "läkemedel", "mat", "ombud", "ämne", "immun", "icke-immun", "kemisk", "anafylaxi", "allergen", "medicin", "tillägg", "läkemedel", "naturläkemedel", "immunologiska", "icke-immunologiska", "risk" ],
          "use" : "*Use to record a clinical assessment of a propensity for an adverse reaction upon future exposure to a specified substance or class of substances including, but not limited to, incipients and excipients in medicinal preparations, biological products, metal salts, and organic chemical compounds.  \r\n\r\nThis archetype is intended to provide a single place within the health record to document the propensity for the full range of reactions, from trivial to life-threatening:\r\n- immune-mediated: Types I-IV (including allergic reactions and hypersensitivities); or \r\n- non-immune-mediated: including pseudo-allergic reactions, side effects, intolerances, and drug toxicities.\r\nIn clinical practice distinguishing between immune-mediated and non-immune-mediated reactions can be difficult. Identification of the type of reaction is not a proxy for seriousness or risk of harm to the patient.\r\n\r\nIdentification of the severity of the manifestation of the reaction can inform the 'Criticality' of the adverse reaction risk - for example, experiencing anaphylaxis on first exposure to a substance would warrant setting a 'Criticality' of 'high', due to the high risk that anaphylaxis is likely to recur on second and subsequent exposures.\r\n\r\nWhere a propensity is identified, information or evidence about one or more reaction events can be recorded using the CLUSTER.adverse_reaction_event archetype in the 'Reaction event summary' SLOT.\r\n\r\nThis archetype has been designed to allow the recording of information about a specific substance (amoxycillin, oysters, or bee sting venom) or, alternatively, a class of substance (e.g. Penicillins). If a class of substance is recorded, identification of the exact substance can be recorded on a per-reaction basis using the CLUSTER.adverse_reaction_event archetype.\r\n\r\nUse to record information about the positive presence of the risk of an adverse reaction:\r\n- to support the direct clinical care of an individual; \r\n- as part of a managed adverse reaction or allergy/intolerance list; \r\n- to support the exchange of information about the propensity and events related to adverse reactions; \r\n- to inform adverse reaction reporting; and \r\n- to assist with computerised knowledge-based activities such as clinical decision support and alerts.\r\n\r\nThe risk of an adverse reaction event or manifestation must always propose a causative substance or class of substance. If there is a degree of uncertainty that a specific substance is the cause, the level of uncertainty can be recorded using the ‘Verification status’ data element. If more than one possible substance may have caused a reaction/manifestation, each substance should be recorded using a separate instance of this adverse reaction risk archetype with the ‘Verification status’ set to an initial state of ‘Unconfirmed’ so that adverse reaction checking can be activated in clinical systems. If the substance is later proven not to be causal then the ‘Verification status’ can be modified to ‘Refuted’ - for example, after allergy testing.\r\n\r\nThe scope of this archetype has deliberately focused on identifying a pragmatic data set that are used in most clinical systems or will be suitable for most common clinical scenarios; however, it permits extension of the model when additional detail is required, using the 'Reaction details', 'Exposure details', and 'Reporting details' slots. An extension may be required if a specialist allergist or immunologist needed to record a more detailed assessment as part of a report to regulatory bodies or within the context of a clinical trial. (en)",
          "misuse" : "*Not to be used for recording physiological reactions to physical agents, such as heat, cold, sunlight, vibration, exercise activity, by infectious agents or food contaminants. Use a specific archetype for EVALUATION.problem/diagnosis or CLUSTER.symptom/sign for this purpose.\r\n\r\nNot to be used to record adverse events, including failures of clinical process, interventions or products. For example: abnormal use, incorrect dosage or maladministration of an agent or substance; mislabelling; harm or injury caused by an intervention or procedure; overdose/poisoning etc. Use a specific archetype for the purpose. \r\n\r\nNot to be used to record an adverse reaction where the substance is unknown. Use EVALUATION.problem_diagnosis or CLUSTER.symptom_sign to record as part of the health record until a possible substance is identified.\r\n\r\nNot to be used to record reactions to transfusions of blood products. Use a specific archetype for this purpose. \r\n\r\nNot to be used for recording 'alerts'. Use EVALUATION.precaution, EVALUATION.contraindication or related archetypes for this purpose.\r\n\r\nNot to be used for recording failed therapy.\r\n\r\nNot to be used for the explicit recording of an absence (or negative presence) of a reaction to 'any substances' or to identified substances, for example ‘No known allergies or adverse reactions’ or ‘No known allergies to Penicillin’. Use the EVALUATION.exclusion_global or EVALUATION.exclusion_specific archetypes to express a positive statement of adverse reaction exclusion.\r\n\r\nNot to be used for the explicit recording that no information was able to be obtained about the adverse reaction status of a patient. Use the EVALUATION.absence archetype to record that a positive statement that information was not able to be obtained, for example, if a non-cooperative patient refuses to answer questions. (en)",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "nb" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "nb"
          },
          "purpose" : "For å registrere en klinisk vurdering om et individs tendens til overfølsomhetsreaksjoner ved eksponering eller re-eksponering for en angitt substans eller substansklasse.",
          "keywords" : [ "reaksjon", "allergi", "allergisk", "uønsket", "hendelse", "virkning", "effekt", "følsomhet", "intoleranse", "hypersensitivtet", "bivirkning", "toksisitet", "legemiddel", "mat", "medisinering", "medisin", "substans", "immun", "non-immun", "kjemisk", "anafylakse", "allergen", "naturmedisin", "immunologisk", "ikke-immunologisk", "non-immunologisk", "risk", "risiko", "supplement", "kosttilskudd", "tilskudd", "anafylaksi", "anafylaktisk", "naturmidler", "medikament", "ernæring", "stoff", "rusmiddel", "agens", "overfølsomhet", "atopi", "cave" ],
          "use" : "Brukes for å registrere en klinisk vurdering om et individs tendens til overfølsomhetsreaksjoner ved fremtidig eksponering for en substans eller substansklasse. Substanser kan omfatte men er ikke begrenset til: aktive stoffer eller hjelpestoffer i legemidler, biologiske produkter, metallsalter eller organiske substanser.\r\n\t\r\nArketypen gir ett enkelt sted i pasientjournalen for å dokumentere tendensen til hele spekteret av reaksjoner, fra trivielle til livstruende:\r\n- immunmediert reaksjon - Typene I-IV (allergiske reaksjoner og hypersensitivitet)\r\n- ikke-immunmediert reaksjon - inkludert annen overfølsomhet, bivirkninger, intoleranse og legemiddeltoksisitet\r\nI klinisk praksis kan det være vanskelig å skille mellom immunmedierte og ikke-immunmedierte reaksjoner. Identifisering av reaksjonstypen er ikke et substitutt for alvorlighetsgrad eller risiko for skade på pasienten.\r\n\r\nDer en tendens er identifisert, kan informasjon eller evidens om en eller flere reaksjonshendelser registreres ved hjelp av arketypen CLUSTER.adverse_reaction_event brukt i SLOTet \"Sammendrag av reaksjonshendelse\".\r\n\r\nReaksjonsmanifestasjonens alvorlighetsgrad, dokumentert ved hjelp av arketypen CLUSTER.adverse_reaction_event, kan brukes til å utlede reaksjonsrisikoens alvorlighetsgrad. For eksempel kan anafylakse ved første eksponering for en substans være grunnlag for å sette alvorlighetsgraden til \"høy\", siden det da vil være høy risiko for en anafylaktisk reaksjon også ved andre gangs eller senere eksponeringer.\r\n\r\nDenne arketypen er designet for å tillate registrering av informasjon om en bestemt substans (f.eks. amoxycillin, østers eller biegift) eller en substansklasse (f.eks. Penicilliner). Hvis en substansklasse registreres kan den spesifikke substansen registreres per reaksjon ved hjelp av arketypen CLUSTER.adverse_reaction_event.\r\n\r\nBrukes til å registrere informasjon om at en risiko for en overfølsomhetsreaksjon er tilstede:\r\n- for å støtte direkte klinisk omsorg for et individ\r\n- som en del av en vedlikeholdt liste over overfølsomhetsreaksjoner\r\n- for å støtte utveksling av informasjon om tendenser og hendelser knyttet til overfølsomhetsreaksjoner\r\n- for å støtte rapportering av reaksjonshendelser\r\n- for å støtte kunnskapsbaserte aktiviteter som klinisk beslutningsstøtte og varsler\r\n\r\nRisikoen for en reaksjonshendelse eller reaksjonsmanifestasjon må alltid foreslår en utløsende substans eller substansklasse. Hvis det er usikkerhet om hvilken spesifikke substans som er årsak til overfølsomhetsreaksjonen, kan denne usikkerheten angis ved hjelp dataelementet \"Verifikasjonsstatus\". Dersom flere mulige substanser kan ha forårsaket en reaksjon/manifestasjon bør hver substans registreres for seg i denne arketypen med \"Verifikasjonsstatus\" i utgangspunktet satt til \"Ubekreftet\", slik at kontroll av overfølsomhetsreaksjoner kan aktiveres i kliniske systemer. Dersom en substans eller substansklasse senere viser seg å ikke være årsaken til reaksjonen, kan \"Verifikasjonsstatus\" endres til \"Avkreftet\".",
          "misuse" : "Brukes ikke til registrering av fysiologiske reaksjoner på fysiske fenomener, som for eksempel varme, kulde, sollys, vibrasjon, treningsaktivitet, smittestoffer eller forurensninger i mat. Til dette brukes en spesifikk arketype som EVALUATION.problem_diagnosis eller CLUSTER.symptom_sign.\r\n\r\nBrukes ikke til å registrere avvik, inkludert svikt i kliniske prosesser, intervensjoner eller produkter. For eksempel: Feil bruk, feil dosering eller feil administrasjon av en substans, feilmerking, skade forårsaket av en intervensjon eller prosedyre, overdose/forgiftning etc. Bruk en spesifikk arketype for dette formålet.\r\n\r\nBrukes ikke til å registerere en uønsket reaksjon hvor substansen er ukjent. Bruk arketypen EVALUATION.problem_diagnosis eller CLUSTER.symptom_sign for å registrere disse inntil substansen blir identifisert.\r\n\r\nBrukes ikke til å registrere reaksjoner på transfusjoner av blodkomponenter. Bruk en spesifikk arketype for dette formålet.\r\n\r\nBrukes ikke for å registrere generiske 'varsler'. Bruk EVALUATION.precaution, EVALUATION.contraindication eller relaterte arketyper for dette formålet.\r\n\r\nBrukes ikke til å registrere mislykket behandling.\r\n\r\nSkal ikke brukes for eksplisitt registrering av et fravær (eller negativ tilstedeværelse) av en reaksjon på en hvilken som helst substans eller til spesifikke substanser, for eksempel \"Ingen kjente allergier eller uønskede reaksjoner\" eller \"Ingen kjent allergi mot penicillin\". Bruk arketypene EVALUATION.exclusion_global eller EVALUATION.exclusion_specific til å uttrykke et eksplisitt utsagn om fravær av uønskede reaksjoner.\r\n\r\nSkal ikke brukes for eksplisitt registrering av at ingen informasjon er tilgjengelig om et individs status med tanke på uønskede reaksjoner. Bruk arketypen EVALUATION.absence til å registrere at informasjon ikke er tilgjengelig, for eksempel dersom en ikke-samarbeidsvillig pasient nekter å svare på spørsmål.",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "pt-br" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "pt-br"
          },
          "purpose" : "*To record the clinical assessment of the propensity for an individual to experience an adverse reaction if exposed, or re-exposed, to a specified substance or class of substances. (en)",
          "keywords" : [ "reação", "alergia", "alérgico", "adversa", "evento", "efeito", "sensibilidade", "intolerância", "hipersensibilidade", "efeito colateral", "toxicidade", "droga", "alimento", "agente", "substância", "imune", "não imune", "químico", "anafilaxia", "alérgeno", "medicação", "suplemento", "medicamento", "remédio natural", "imunológico", "não imunológico", "risco" ],
          "use" : "*Use to record a clinical assessment of a propensity for an adverse reaction upon future exposure to a specified substance or class of substances including, but not limited to, incipients and excipients in medicinal preparations, biological products, metal salts, and organic chemical compounds.  \r\n\r\nThis archetype is intended to provide a single place within the health record to document the propensity for the full range of reactions, from trivial to life-threatening:\r\n- immune-mediated: Types I-IV (including allergic reactions and hypersensitivities); or \r\n- non-immune-mediated: including pseudo-allergic reactions, side effects, intolerances, and drug toxicities.\r\nIn clinical practice distinguishing between immune-mediated and non-immune-mediated reactions can be difficult. Identification of the type of reaction is not a proxy for seriousness or risk of harm to the patient.\r\n\r\nIdentification of the severity of the manifestation of the reaction can inform the 'Criticality' of the adverse reaction risk - for example, experiencing anaphylaxis on first exposure to a substance would warrant setting a 'Criticality' of 'high', due to the high risk that anaphylaxis is likely to recur on second and subsequent exposures.\r\n\r\nWhere a propensity is identified, information or evidence about one or more reaction events can be recorded using the CLUSTER.adverse_reaction_event archetype in the 'Reaction event summary' SLOT.\r\n\r\nThis archetype has been designed to allow the recording of information about a specific substance (amoxycillin, oysters, or bee sting venom) or, alternatively, a class of substance (e.g. Penicillins). If a class of substance is recorded, identification of the exact substance can be recorded on a per-reaction basis using the CLUSTER.adverse_reaction_event archetype.\r\n\r\nUse to record information about the positive presence of the risk of an adverse reaction:\r\n- to support the direct clinical care of an individual; \r\n- as part of a managed adverse reaction or allergy/intolerance list; \r\n- to support the exchange of information about the propensity and events related to adverse reactions; \r\n- to inform adverse reaction reporting; and \r\n- to assist with computerised knowledge-based activities such as clinical decision support and alerts.\r\n\r\nThe risk of an adverse reaction event or manifestation must always propose a causative substance or class of substance. If there is a degree of uncertainty that a specific substance is the cause, the level of uncertainty can be recorded using the ‘Verification status’ data element. If more than one possible substance may have caused a reaction/manifestation, each substance should be recorded using a separate instance of this adverse reaction risk archetype with the ‘Verification status’ set to an initial state of ‘Unconfirmed’ so that adverse reaction checking can be activated in clinical systems. If the substance is later proven not to be causal then the ‘Verification status’ can be modified to ‘Refuted’ - for example, after allergy testing.\r\n\r\nThe scope of this archetype has deliberately focused on identifying a pragmatic data set that are used in most clinical systems or will be suitable for most common clinical scenarios; however, it permits extension of the model when additional detail is required, using the 'Reaction details', 'Exposure details', and 'Reporting details' slots. An extension may be required if a specialist allergist or immunologist needed to record a more detailed assessment as part of a report to regulatory bodies or within the context of a clinical trial. (en)",
          "misuse" : "*Not to be used for recording physiological reactions to physical agents, such as heat, cold, sunlight, vibration, exercise activity, by infectious agents or food contaminants. Use a specific archetype for EVALUATION.problem/diagnosis or CLUSTER.symptom/sign for this purpose.\r\n\r\nNot to be used to record adverse events, including failures of clinical process, interventions or products. For example: abnormal use, incorrect dosage or maladministration of an agent or substance; mislabelling; harm or injury caused by an intervention or procedure; overdose/poisoning etc. Use a specific archetype for the purpose. \r\n\r\nNot to be used to record an adverse reaction where the substance is unknown. Use EVALUATION.problem_diagnosis or CLUSTER.symptom_sign to record as part of the health record until a possible substance is identified.\r\n\r\nNot to be used to record reactions to transfusions of blood products. Use a specific archetype for this purpose. \r\n\r\nNot to be used for recording 'alerts'. Use EVALUATION.precaution, EVALUATION.contraindication or related archetypes for this purpose.\r\n\r\nNot to be used for recording failed therapy.\r\n\r\nNot to be used for the explicit recording of an absence (or negative presence) of a reaction to 'any substances' or to identified substances, for example ‘No known allergies or adverse reactions’ or ‘No known allergies to Penicillin’. Use the EVALUATION.exclusion_global or EVALUATION.exclusion_specific archetypes to express a positive statement of adverse reaction exclusion.\r\n\r\nNot to be used for the explicit recording that no information was able to be obtained about the adverse reaction status of a patient. Use the EVALUATION.absence archetype to record that a positive statement that information was not able to be obtained, for example, if a non-cooperative patient refuses to answer questions. (en)",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "en" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "en"
          },
          "purpose" : "To record the clinical assessment of the propensity for an individual to experience an adverse reaction if exposed, or re-exposed, to a specified substance or class of substances.",
          "keywords" : [ "reaction", "allergy", "allergic", "adverse", "event", "effect", "sensitivity", "intolerance", "hypersensitivity", "side effect", "toxicity", "drug", "food", "agent", "substance", "immune", "non-immune", "chemical", "anaphylaxis", "allergen", "medication", "supplement", "medicine", "natural remedies", "immunological", "non-immunological", "risk" ],
          "use" : "Use to record a clinical assessment of a propensity for an adverse reaction upon future exposure to a specified substance or class of substances including, but not limited to, incipients and excipients in medicinal preparations, biological products, metal salts, and organic chemical compounds. \r\n\r\nThis archetype is intended to provide a single place within the health record to document the propensity for the full range of reactions, from trivial to life-threatening:\r\n- immune-mediated: Types I-IV (including allergic reactions and hypersensitivities); or \r\n- non-immune-mediated: including pseudo-allergic reactions, side effects, intolerances, and drug toxicities.\r\nIn clinical practice distinguishing between immune-mediated and non-immune-mediated reactions can be difficult. Identification of the type of reaction is not a proxy for seriousness or risk of harm to the patient.\r\n\r\nWhere a propensity is identified, information or evidence about one or more reaction events can be recorded using the CLUSTER.adverse_reaction_event archetype in the 'Reaction event summary' SLOT.\r\n\r\nIdentification of the severity of the manifestation of the reaction, recorded in the CLUSTER.adverse_reaction_event archetype, can inform the 'Criticality' of the adverse reaction risk. For example, experiencing anaphylaxis on first exposure to a substance would warrant setting a 'Criticality' of 'high', due to the high risk that anaphylaxis is likely to recur on second and subsequent exposures.\r\n\r\nThis archetype has been designed to allow the recording of information about a specific substance (amoxycillin, oysters, or bee sting venom) or, alternatively, a class of substance (e.g. Penicillins). If a class of substance is recorded, identification of the exact substance can be recorded on a per-reaction basis using the CLUSTER.adverse_reaction_event archetype.\r\n\r\nUse to record information about the positive presence of the risk of an adverse reaction:\r\n- to support the direct clinical care of an individual; \r\n- as part of a managed adverse reaction or allergy/intolerance list; \r\n- to support the exchange of information about the propensity and events related to adverse reactions; \r\n- to inform adverse reaction reporting; and \r\n- to assist with computerised knowledge-based activities such as clinical decision support and alerts.\r\n\r\nThe risk of an adverse reaction event or manifestation must always propose a causative substance or class of substance. If there is a degree of uncertainty that a specific substance is the cause, the level of uncertainty can be recorded using the ‘Verification status’ data element. If more than one possible substance may have caused a reaction/manifestation, each substance should be recorded using a separate instance of this adverse reaction risk archetype with the ‘Verification status’ set to an initial state of ‘Unconfirmed’ so that adverse reaction checking can be activated in clinical systems. If the substance is later proven not to be causal then the ‘Verification status’ can be modified to ‘Refuted’ - for example, after allergy testing.",
          "misuse" : "Not to be used for recording physiological reactions to physical agents, such as heat, cold, sunlight, vibration, exercise activity, by infectious agents or food contaminants. Use a specific archetype for EVALUATION.problem/diagnosis or CLUSTER.symptom/sign for this purpose.\r\n\r\nNot to be used to record adverse events, including failures of clinical process, interventions or products. For example: abnormal use, incorrect dosage or maladministration of an agent or substance; mislabelling; harm or injury caused by an intervention or procedure; overdose/poisoning etc. Use a specific archetype for the purpose. \r\n\r\nNot to be used to record an adverse reaction where the substance is unknown. Use EVALUATION.problem_diagnosis or CLUSTER.symptom_sign to record as part of the health record until a possible substance is identified.\r\n\r\nNot to be used to record reactions to transfusions of blood products. Use a specific archetype for this purpose. \r\n\r\nNot to be used for recording 'alerts'. Use EVALUATION.precaution, EVALUATION.contraindication or related archetypes for this purpose.\r\n\r\nNot to be used for recording failed therapy.\r\n\r\nNot to be used for the explicit recording of an absence (or negative presence) of a reaction to 'any substances' or to identified substances, for example ‘No known allergies or adverse reactions’ or ‘No known allergies to Penicillin’. Use the EVALUATION.exclusion_global or EVALUATION.exclusion_specific archetypes to express a positive statement of adverse reaction exclusion.\r\n\r\nNot to be used for the explicit recording that no information was able to be obtained about the adverse reaction status of a patient. Use the EVALUATION.absence archetype to record that a positive statement that information was not able to be obtained, for example, if a non-cooperative patient refuses to answer questions.",
          "copyright" : "© Australian Digital Health Agency, openEHR Foundation, HL7 International, Nasjonal IKT",
          "originalResourceUri" : { },
          "otherDetails" : { }
        }
      }
    },
    "annotations" : {
      "@type" : "RESOURCE_ANNOTATIONS",
      "documentation" : {
        "en" : {
          "" : {
            "source" : "openEHR,FHIR"
          }
        },
        "pt-br" : {
          "/data[at0001]/items[at0002]" : {
            "source" : "*openEHR,FHIR,DAM(en)"
          }
        },
        "nb" : { },
        "de" : {
          "" : {
            "source" : "openEHR, FHIR"
          },
          "/data[at0001]/items[at0002]" : {
            "source" : "openEHR, FHIR, DAM"
          },
          "/data[at0001]/items[at0101]" : {
            "source" : "DAM, openEHR"
          },
          "/data[at0001]/items[at0063.1]" : {
            "source" : "FHIR, DAM"
          },
          "/data[at0001]/items[at0117.1]" : {
            "source" : "IMH"
          },
          "/data[at0001]/items[at0058.1]" : {
            "source" : "FHIR, DAM"
          },
          "/data[at0001]/items[at0006.1]" : {
            "source" : "openEHR"
          },
          "/protocol[at0042]/items[at0062.1]" : {
            "source" : "openEHR, FHIR, DAM"
          },
          "/protocol[at0042]/items[at0047.1]" : {
            "source" : "FHIR, openEHR, DAM"
          }
        },
        "sv" : {
          "/data[at0001]/items[at0002]" : {
            "source" : "openEHR,FHIR,DAM"
          },
          "/data[at0001]/items[at0101]" : {
            "source" : "DAM, openEHR"
          },
          "/data[at0001]/items[at0063.1]" : {
            "source" : "FHIR, DAM"
          },
          "/data[at0001]/items[at0117.1]" : {
            "source" : "IMH"
          },
          "/data[at0001]/items[at0058.1]" : {
            "source" : "FHIR, DAM"
          },
          "/data[at0001]/items[at0006.1]" : {
            "source" : "openEHR"
          },
          "/protocol[at0042]/items[at0047.1]" : {
            "source" : "FHIR, openEHR, DAM"
          }
        }
      }
    },
    "parentArchetypeId" : "openEHR-EHR-EVALUATION.adverse_reaction_risk.v2",
    "differential" : false,
    "archetypeId" : {
      "@type" : "ARCHETYPE_HRID",
      "value" : "openEHR-EHR-EVALUATION.ovl-adverse_reaction_risk-001.v2"
    },
    "definition" : {
      "@type" : "C_COMPLEX_OBJECT",
      "rmTypeName" : "EVALUATION",
      "occurrences" : "1..1",
      "nodeId" : "at0000.1",
      "attributes" : [ {
        "@type" : "C_ATTRIBUTE",
        "rmAttributeName" : "data",
        "existence" : "1..1",
        "children" : [ {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ITEM_TREE",
          "occurrences" : "1..1",
          "nodeId" : "at0001",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "items",
            "existence" : "0..1",
            "cardinality" : {
              "@type" : "CARDINALITY",
              "interval" : "1..*",
              "ordered" : false,
              "unique" : false
            },
            "children" : [ {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "1..1",
              "nodeId" : "at0002",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0130.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_CODED_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ {
                    "@type" : "C_ATTRIBUTE",
                    "rmAttributeName" : "defining_code",
                    "existence" : "1..1",
                    "children" : [ {
                      "@type" : "C_TERMINOLOGY_CODE",
                      "rmTypeName" : "TERMINOLOGY_CODE",
                      "occurrences" : "1..1",
                      "terminologyId" : {
                        "value" : "local"
                      },
                      "constraint" : [ "ac0.2" ],
                      "selectedTerminologies" : [ ]
                    } ]
                  } ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0063.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_CODED_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ {
                    "@type" : "C_ATTRIBUTE",
                    "rmAttributeName" : "defining_code",
                    "existence" : "1..1",
                    "children" : [ {
                      "@type" : "C_TERMINOLOGY_CODE",
                      "rmTypeName" : "TERMINOLOGY_CODE",
                      "occurrences" : "1..1",
                      "terminologyId" : {
                        "value" : "local"
                      },
                      "constraint" : [ "ac0.1" ],
                      "selectedTerminologies" : [ ]
                    } ]
                  } ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..1",
              "nodeId" : "at0101",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_CODED_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ {
                    "@type" : "C_ATTRIBUTE",
                    "rmAttributeName" : "defining_code",
                    "existence" : "1..1",
                    "children" : [ {
                      "@type" : "C_TERMINOLOGY_CODE",
                      "rmTypeName" : "CODE_PHRASE",
                      "occurrences" : "1..1",
                      "terminologyId" : {
                        "value" : "local"
                      },
                      "constraint" : [ "at0102", "at0103", "at0124" ]
                    } ]
                  } ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0120.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_CODED_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ {
                    "@type" : "C_ATTRIBUTE",
                    "rmAttributeName" : "defining_code",
                    "existence" : "1..1",
                    "children" : [ {
                      "@type" : "C_TERMINOLOGY_CODE",
                      "rmTypeName" : "TERMINOLOGY_CODE",
                      "occurrences" : "1..1",
                      "terminologyId" : {
                        "value" : "local"
                      },
                      "constraint" : [ "ac0.3" ],
                      "selectedTerminologies" : [ ]
                    } ]
                  } ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0117.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DURATION",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_INTERVAL<DV_DATE_TIME>",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_INTERVAL<DV_DURATION>",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0133.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DURATION",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_INTERVAL<DV_DATE_TIME>",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_INTERVAL<DV_DURATION>",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0058.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_CODED_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ {
                    "@type" : "C_ATTRIBUTE",
                    "rmAttributeName" : "defining_code",
                    "existence" : "1..1",
                    "children" : [ {
                      "@type" : "C_TERMINOLOGY_CODE",
                      "rmTypeName" : "TERMINOLOGY_CODE",
                      "occurrences" : "1..1",
                      "terminologyId" : {
                        "value" : "local"
                      },
                      "constraint" : [ "ac0.4" ],
                      "selectedTerminologies" : [ ]
                    } ]
                  } ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "ARCHETYPE_SLOT",
              "rmTypeName" : "CLUSTER",
              "occurrences" : "0..*",
              "nodeId" : "at0129",
              "includes" : [ {
                "@type" : "ASSERTION",
                "stringExpression" : "archetype_id/value matches {/openEHR-EHR-CLUSTER\\.adverse_reaction_event(-[a-zA-Z0-9_]+)*\\.v0|openEHR-EHR-CLUSTER\\.adverse_reaction_event(-[a-zA-Z0-9_]+)*\\.v1/}",
                "expression" : {
                  "@type" : "BINARY_OPERATOR",
                  "type" : "BOOLEAN",
                  "operator" : "matches",
                  "leftOperand" : {
                    "@type" : "MODEL_REFERENCE",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Attribute",
                    "path" : "archetype_id/value"
                  },
                  "rightOperand" : {
                    "@type" : "CONSTRAINT",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Constraint",
                    "item" : {
                      "@type" : "C_STRING",
                      "constraint" : [ "/openEHR-EHR-CLUSTER\\.adverse_reaction_event(-[a-zA-Z0-9_]+)*\\.v0|openEHR-EHR-CLUSTER\\.adverse_reaction_event(-[a-zA-Z0-9_]+)*\\.v1/" ]
                    }
                  },
                  "precedenceOverriden" : false
                },
                "variables" : [ ]
              } ],
              "excludes" : [ ],
              "closed" : false
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0006.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            } ]
          } ],
          "attributeTuples" : [ ]
        } ]
      }, {
        "@type" : "C_ATTRIBUTE",
        "rmAttributeName" : "protocol",
        "existence" : "0..1",
        "children" : [ {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ITEM_TREE",
          "occurrences" : "1..1",
          "nodeId" : "at0042",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "items",
            "existence" : "0..1",
            "cardinality" : {
              "@type" : "CARDINALITY",
              "interval" : "1..*",
              "ordered" : false,
              "unique" : false
            },
            "children" : [ {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0062.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0047.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_EHR_URI",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "ARCHETYPE_SLOT",
              "rmTypeName" : "CLUSTER",
              "occurrences" : "0..*",
              "nodeId" : "at0128",
              "includes" : [ {
                "@type" : "ASSERTION",
                "stringExpression" : "archetype_id/value matches {/.*/}",
                "expression" : {
                  "@type" : "BINARY_OPERATOR",
                  "type" : "BOOLEAN",
                  "operator" : "matches",
                  "leftOperand" : {
                    "@type" : "MODEL_REFERENCE",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Attribute",
                    "path" : "archetype_id/value"
                  },
                  "rightOperand" : {
                    "@type" : "CONSTRAINT",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Constraint",
                    "item" : {
                      "@type" : "C_STRING",
                      "constraint" : [ "/.*/" ]
                    }
                  },
                  "precedenceOverriden" : false
                },
                "variables" : [ ]
              } ],
              "excludes" : [ ],
              "closed" : false
            } ]
          } ],
          "attributeTuples" : [ ]
        } ]
      } ],
      "attributeTuples" : [ ]
    },
    "terminology" : {
      "@type" : "ARCHETYPE_TERMINOLOGY",
      "conceptCode" : "at0000",
      "termDefinitions" : {
        "en" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "(Synthesized)",
            "code" : "ac0.1",
            "description" : ""
          },
          "ac0.2" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "(Synthesized)",
            "code" : "ac0.2",
            "description" : ""
          },
          "ac0.3" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "(Synthesized)",
            "code" : "ac0.3",
            "description" : ""
          },
          "ac0.4" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "(Synthesized)",
            "code" : "ac0.4",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Adverse reaction risk",
            "description" : "Clinical assessment of the propensity for an individual to experience a harmful or undesirable physiological response if exposed, or re-exposed, to a substance.",
            "comment" : "Substances include, but are not limited to: a therapeutic substance administered correctly at an appropriate dosage for the individual; food; material derived from plants or animals; or venom from insect stings.",
            "source" : "openEHR,FHIR"
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Substance",
            "description" : "Identification of a substance, or substance class, that is considered to put the individual at risk of an adverse reaction event.",
            "comment" : "Both an individual substance and a substance class are valid entries in 'Substance'. A substance may be a compound of simpler substances, for example a medicinal product. It is strongly recommended that the 'Substance' is coded with a terminology capable of triggering decision support, where possible. For example: Snomed CT, DM+D, RxNorm, NDFRT, ATC, New Zealand Universal List of Medicines and Australian Medicines Terminology. Free text entry should only be used if there is no appropriate terminology available."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Comment",
            "description" : "Additional narrative about the propensity for the adverse reaction, not captured in other fields.",
            "comment" : "For example: including reason for flagging a 'Criticality' of 'High risk'; and instructions related to future exposure or administration of the Substance, such as administration within an Intensive Care Unit or under corticosteroid cover."
          },
          "at0042" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0042",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0047" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Supporting clinical record information",
            "description" : "Link to further information about the presentation and findings that exist elsewhere in the health record, including allergy test reports.",
            "comment" : "For example, presenting symptoms, examination findings, diagnosis etc."
          },
          "at0058" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaction mechanism",
            "description" : "Identification of the underlying physiological mechanism for the adverse reaction.",
            "comment" : "Immune-mediated responses have been traditionally regarded as an indicator for escalation of significant future risk. Contemporary knowledge suggests that some reactions previously thought to be immune are actually non-immune and still carry life threatening risk. \r\n\r\nImmunological testing may provide supporting evidence for the mechanism and causative substance , but no tests are 100% sensitive or specific for a sensitivity. \r\n\r\nIt is acknowledged that most clinicians will NOT be able to distinguish the mechanism of any specific reaction. However this data element is included because many legacy systems have captured this attribute."
          },
          "at0059" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0059",
            "text" : "Immune mediated",
            "description" : "Immune mediated reaction, including allergic reactions and hypersensitivities."
          },
          "at0060" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0060",
            "text" : "Non-immune mediated",
            "description" : "A non-immune mediated reaction, which can include pseudo-allergic reactions, side effects, intolerances, drug toxicities (for example, to Gentamicin)."
          },
          "at0062" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Last updated",
            "description" : "Date when the propensity or the reaction event was updated."
          },
          "at0063" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "Verification status",
            "description" : "Assertion about the certainty of the propensity, or potential future risk, of the identified 'Substance' to cause a reaction.",
            "comment" : "Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology."
          },
          "at0064" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0064",
            "text" : "Unconfirmed",
            "description" : "The propensity for a reaction to the identified 'Substance' has not been objectively verified."
          },
          "at0065" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0065",
            "text" : "Confirmed",
            "description" : "The propensity for a reaction to the identified 'Substance' has been objectively verified. This may include clinical evidence by testing, re-challenge or observation."
          },
          "at0066" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0066",
            "text" : "Refuted",
            "description" : "A propensity for a reaction to the identified 'Substance' has been disputed or disproven with a sufficient level of clinical certainty to justify invalidating the assertion. This may include clinical evidence by testing, re-challenge or observation."
          },
          "at0101" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0101",
            "text" : "Criticality",
            "description" : "An indication of the potential for critical system organ damage or life threatening consequence.",
            "comment" : "This can be regarded as a predictive judgement of a 'worst case scenario'. In most contexts 'Low' would be regarded as the default value."
          },
          "at0102" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0102",
            "text" : "Low",
            "description" : "Exposure to substance unlikely to result in critical system organ damage or life threatening consequence. Future exposure to the identified 'Substance' should be considered a relative contra-indication in normal clinical circumstances."
          },
          "at0103" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0103",
            "text" : "High",
            "description" : "Exposure to substance may result in critical organ system damage or life threatening consequence. Future exposure to the identified 'Substance' should be considered an absolute contra-indication in normal clinical circumstances."
          },
          "at0117" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Onset of last reaction",
            "description" : "The date and/or time of the onset of the last known occurrence of a reaction event.",
            "comment" : "For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year."
          },
          "at0120" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Category",
            "description" : "Category of the identified 'Substance'.",
            "comment" : "This data element has been included because it is currently being captured in some clinical systems. This data can be derived from the Substance where coding systems are used, and is effectively redundant in that situation."
          },
          "at0121" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0121",
            "text" : "Food",
            "description" : "Any substance consumed to provide nutritional support for the body, such as peanut or egg."
          },
          "at0122" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0122",
            "text" : "Medication",
            "description" : "Any substance administered to achieve a physiological effect."
          },
          "at0123" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0123",
            "text" : "Other",
            "description" : "Any other substance encountered including venom, latex and other environmental substances."
          },
          "at0124" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0124",
            "text" : "Indeterminate",
            "description" : "Unable to assess with information available."
          },
          "at0126" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0126",
            "text" : "Indeterminate",
            "description" : "The physiological mechanism could not be determined."
          },
          "at0128" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0128",
            "text" : "Extension",
            "description" : "Additional information required to capture local content or to align with other reference models/formalisms.",
            "comment" : "For example: local information requirements or additional metadata to align with FHIR equivalents."
          },
          "at0129" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0129",
            "text" : "Reaction event summary",
            "description" : "Summary details about each adverse reaction event linked to exposure to the identified 'Substance'."
          },
          "at0130" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "Active/inactive status",
            "description" : "Status about whether the adverse reaction risk statement is active or inactive."
          },
          "at0131" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0131",
            "text" : "Active",
            "description" : "The subject is currently experiencing, or is at risk of, a reaction to the identified substance."
          },
          "at0132" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0132",
            "text" : "Inactive",
            "description" : "The subject is no longer at risk of a reaction to the identified substance."
          },
          "at0133" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "Onset of first reaction",
            "description" : "The onset of the first known occurrence of a reaction event.",
            "comment" : "For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year."
          },
          "at0133.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "Onset of first reaction",
            "description" : "The onset of the first known occurrence of a reaction event.",
            "comment" : "For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year."
          },
          "at0120.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Category",
            "description" : "Category of the identified 'Substance'.",
            "comment" : "This data element has been included because it is currently being captured in some clinical systems. This data can be derived from the Substance where coding systems are used, and is effectively redundant in that situation."
          },
          "at0130.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "Active/inactive status",
            "description" : "Status about whether the adverse reaction risk statement is active or inactive."
          },
          "at0058.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaction mechanism",
            "description" : "Identification of the underlying physiological mechanism for the adverse reaction.",
            "comment" : "Immune-mediated responses have been traditionally regarded as an indicator for escalation of significant future risk. Contemporary knowledge suggests that some reactions previously thought to be immune are actually non-immune and still carry life threatening risk. \r\n\r\nImmunological testing may provide supporting evidence for the mechanism and causative substance , but no tests are 100% sensitive or specific for a sensitivity. \r\n\r\nIt is acknowledged that most clinicians will NOT be able to distinguish the mechanism of any specific reaction. However this data element is included because many legacy systems have captured this attribute."
          },
          "at0047.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Supporting clinical record information",
            "description" : "Link to further information about the presentation and findings that exist elsewhere in the health record, including allergy test reports.",
            "comment" : "For example, presenting symptoms, examination findings, diagnosis etc."
          },
          "at0006.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Comment",
            "description" : "Additional narrative about the propensity for the adverse reaction, not captured in other fields.",
            "comment" : "For example: including reason for flagging a 'Criticality' of 'High risk'; and instructions related to future exposure or administration of the Substance, such as administration within an Intensive Care Unit or under corticosteroid cover."
          },
          "at0063.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "Verification status",
            "description" : "Assertion about the certainty of the propensity, or potential future risk, of the identified 'Substance' to cause a reaction.",
            "comment" : "Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology."
          },
          "at0062.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Last updated",
            "description" : "Date when the propensity or the reaction event was updated."
          },
          "at0117.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Onset of last reaction",
            "description" : "The date and/or time of the onset of the last known occurrence of a reaction event.",
            "comment" : "For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Adverse reaction risk",
            "description" : "Clinical assessment of the propensity for an individual to experience a harmful or undesirable physiological response if exposed, or re-exposed, to a substance.",
            "comment" : "Substances include, but are not limited to: a therapeutic substance administered correctly at an appropriate dosage for the individual; food; material derived from plants or animals; or venom from insect stings.",
            "source" : "openEHR,FHIR"
          }
        },
        "pt-br" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "ac0.2" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.2",
            "description" : ""
          },
          "ac0.3" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.3",
            "description" : ""
          },
          "ac0.4" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.4",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Risco de Reação Adversa",
            "description" : "*Clinical assessment of the propensity for an individual to experience a harmful or undesirable physiological response if exposed, or re-exposed, to a substance. (en)",
            "comment" : "As substâncias incluem , mas não estão limitadas a: uma substância terapêutica administrada corretamente a uma dosagem apropriada para o indivíduo; alimento; material derivado de plantas ou animais ; ou veneno de picadas de insetos"
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "*Substance(en)",
            "description" : "*Identification of a substance, or substance class, that is considered to put the individual at risk of an adverse reaction event.(en)",
            "comment" : "*Both an individual substance and a substance class are valid entries in 'Substance'. A substance may be a compound of simpler substances, for example a medicinal product. It is strongly recommended that the 'Substance' is coded with a terminology capable of triggering decision support, where possible. For example: Snomed CT, DM+D, RxNorm, NDFRT, ATC, New Zealand Universal List of Medicines and Australian Medicines Terminology. Free text entry should only be used if there is no appropriate terminology available. (en)",
            "source" : "*openEHR,FHIR,DAM(en)"
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Comentários",
            "description" : "Narrativa adicional sobre a propensão para a reação adversa, não capturada em outros campos.",
            "comment" : "Por exemplo: incluir motivo para sinalizar uma criticidade de alto risco; e instruções relacionadas com a exposição futura ou a administração da substância, tais como a administração dentro de uma unidade de terapia intensiva ou sob cobertura de corticosteróide"
          },
          "at0042" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0042",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0047" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Apoio às informações clínicas do registro",
            "description" : "Link para mais informações sobre a apresentação e as conclusões que existe em outro lugar no registro de saúde, incluindo relatórios de teste de alergia.",
            "comment" : "*For example, presenting symptoms, examination findings, diagnosis etc. (en)"
          },
          "at0058" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Mecanismo da Reação",
            "description" : "Identificação do mecanismo fisiológico subjacente para a reação adversa",
            "comment" : "Respostas imune-mediada tem sido tradicionalmente consideradas como um indicador para a escalada de risco significativo no futuro. Conhecimentos atuais sugerem que algumas reações que previamente se pensava serem imunes são na verdade não imunes e ainda carregam o risco de ameaça à vida.\r\n\r\nTestes imunológicos podem fornecer elementos de prova para o mecanismo e a substância causal, mas os testes não são 100% sensíveis ou específicos para uma sensibilidade.\r\n\r\nÉ reconhecido que a maioria dos clínicos não serão capazes de distinguir o mecanismo de qualquer reação específica. No entanto, este elemento de dados está incluído porque muitos sistemas legados tem capturado esse atributo"
          },
          "at0059" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0059",
            "text" : "Imune - mediada",
            "description" : "Reação imune-mediada, incluindo hipersensibilidade e reações alérgicas."
          },
          "at0060" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0060",
            "text" : "Não imune-mediada",
            "description" : "Reação Não Imuno-mediada, que inclui pseudo alergias, intolerâncias, efeitos colaterais, toxicidade de drogas (por exemplo, a gentamicina)."
          },
          "at0062" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Ultima atualização",
            "description" : "Data quando a propensão ou o evento de reação foi atualizado."
          },
          "at0063" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "*Verification status (en)",
            "description" : "Declaração sobre a certeza da propensão ou potenciais riscos futuros, da substância identificada para causar uma reação.",
            "comment" : "*Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology. (en)"
          },
          "at0064" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0064",
            "text" : "*Unconfirmed (en)",
            "description" : "*The propensity for a reaction to the identified 'Substance' has not been objectively verified. (en)"
          },
          "at0065" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0065",
            "text" : "Confirmada",
            "description" : "*The propensity for a reaction to the identified 'Substance' has been objectively verified. This may include clinical evidence by testing, re-challenge or observation. (en)"
          },
          "at0066" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0066",
            "text" : "Refutada",
            "description" : "*A propensity for a reaction to the identified 'Substance' has been disputed or disproven with a sufficient level of clinical certainty to justify invalidating the assertion. This may include clinical evidence by testing, re-challenge or observation. (en)"
          },
          "at0101" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0101",
            "text" : "Criticidade",
            "description" : "Uma indicação do potencial de danos nos órgãos críticos do sistema ou conseqüência de ameaça à vida",
            "comment" : "*This can be regarded as a predictive judgement of a 'worst case scenario'. In most contexts 'Low' would be regarded as the default value. (en)"
          },
          "at0102" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0102",
            "text" : "Baixo",
            "description" : "Exposição a substâncias passíveis de danos nos órgãos críticos do sistema ou conseqüência de ameaça à vida. Futura exposição à substância identificada deve ser considerada uma contra-indicação relativa em circunstâncias clínicas normais."
          },
          "at0103" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0103",
            "text" : "Alto",
            "description" : "Exposição à substância pode resultar em danos ao sistema, órgão crítico ou conseqüência de ameaça à vida. Futura exposição à substância identificada deve ser considerada uma contra-indicação absoluta em circunstâncias clínicas normais."
          },
          "at0117" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Início da última reação",
            "description" : "A data e/ou hora do início da última ocorrência de um evento de reação conhecida.",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)"
          },
          "at0120" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Categoria",
            "description" : "Categoria da substância identificada",
            "comment" : "Este elemento de dados foi incluído porque atualmente está sendo capturado em alguns sistemas clínicos. Esses dados podem ser derivados da substância onde são utilizados sistemas de codificação e é efetivamente redundante nessa situação."
          },
          "at0121" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0121",
            "text" : "Alimentos",
            "description" : "Qualquer substância consumida para fornecer suporte nutricional para o organismo, tais como o amendoim ou ovo."
          },
          "at0122" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0122",
            "text" : "Medicação",
            "description" : "Qualquer substância administrada para alcançar um efeito fisiológico."
          },
          "at0123" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0123",
            "text" : "Outros",
            "description" : "Qualquer outra substância encontrada incluindo veneno, látex e outras substâncias ambientais."
          },
          "at0124" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0124",
            "text" : "Indeterminado",
            "description" : "Não é possível avaliar com informações disponíveis."
          },
          "at0126" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0126",
            "text" : "Indeterminada",
            "description" : "O mecanismo fisiológico não pôde ser determinado."
          },
          "at0128" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0128",
            "text" : "*Extension(en)",
            "description" : "*Additional information required to capture local content or to align with other reference models/formalisms.(en)",
            "comment" : "*For example: local information requirements or additional metadata to align with FHIR equivalents. (en)"
          },
          "at0129" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0129",
            "text" : "*Reaction event summary (en)",
            "description" : "*Summary details about each adverse reaction event linked to exposure to the identified 'Substance'. (en)"
          },
          "at0130" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "*Active/inactive status (en)",
            "description" : "*Status about whether the adverse reaction risk statement is active or inactive. (en)"
          },
          "at0131" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0131",
            "text" : "*Active (en)",
            "description" : "*The subject is currently experiencing, or is at risk of, a reaction to the identified substance. (en)"
          },
          "at0132" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0132",
            "text" : "*Inactive (en)",
            "description" : "*The subject is no longer at risk of a reaction to the identified substance. (en)"
          },
          "at0133" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "*Onset of first reaction (en)",
            "description" : "*The onset of the first known occurrence of a reaction event. (en)",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)"
          },
          "at0133.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "*Onset of first reaction (en)",
            "description" : "*The onset of the first known occurrence of a reaction event. (en)",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)"
          },
          "at0120.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Categoria",
            "description" : "Categoria da substância identificada",
            "comment" : "Este elemento de dados foi incluído porque atualmente está sendo capturado em alguns sistemas clínicos. Esses dados podem ser derivados da substância onde são utilizados sistemas de codificação e é efetivamente redundante nessa situação."
          },
          "at0130.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "*Active/inactive status (en)",
            "description" : "*Status about whether the adverse reaction risk statement is active or inactive. (en)"
          },
          "at0058.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Mecanismo da Reação",
            "description" : "Identificação do mecanismo fisiológico subjacente para a reação adversa",
            "comment" : "Respostas imune-mediada tem sido tradicionalmente consideradas como um indicador para a escalada de risco significativo no futuro. Conhecimentos atuais sugerem que algumas reações que previamente se pensava serem imunes são na verdade não imunes e ainda carregam o risco de ameaça à vida.\r\n\r\nTestes imunológicos podem fornecer elementos de prova para o mecanismo e a substância causal, mas os testes não são 100% sensíveis ou específicos para uma sensibilidade.\r\n\r\nÉ reconhecido que a maioria dos clínicos não serão capazes de distinguir o mecanismo de qualquer reação específica. No entanto, este elemento de dados está incluído porque muitos sistemas legados tem capturado esse atributo"
          },
          "at0047.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Apoio às informações clínicas do registro",
            "description" : "Link para mais informações sobre a apresentação e as conclusões que existe em outro lugar no registro de saúde, incluindo relatórios de teste de alergia.",
            "comment" : "*For example, presenting symptoms, examination findings, diagnosis etc. (en)"
          },
          "at0006.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Comentários",
            "description" : "Narrativa adicional sobre a propensão para a reação adversa, não capturada em outros campos.",
            "comment" : "Por exemplo: incluir motivo para sinalizar uma criticidade de alto risco; e instruções relacionadas com a exposição futura ou a administração da substância, tais como a administração dentro de uma unidade de terapia intensiva ou sob cobertura de corticosteróide"
          },
          "at0063.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "*Verification status (en)",
            "description" : "Declaração sobre a certeza da propensão ou potenciais riscos futuros, da substância identificada para causar uma reação.",
            "comment" : "*Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology. (en)"
          },
          "at0062.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Ultima atualização",
            "description" : "Data quando a propensão ou o evento de reação foi atualizado."
          },
          "at0117.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Início da última reação",
            "description" : "A data e/ou hora do início da última ocorrência de um evento de reação conhecida.",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)"
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Risco de Reação Adversa",
            "description" : "*Clinical assessment of the propensity for an individual to experience a harmful or undesirable physiological response if exposed, or re-exposed, to a substance. (en)",
            "comment" : "As substâncias incluem , mas não estão limitadas a: uma substância terapêutica administrada corretamente a uma dosagem apropriada para o indivíduo; alimento; material derivado de plantas ou animais ; ou veneno de picadas de insetos"
          }
        },
        "nb" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "ac0.2" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.2",
            "description" : ""
          },
          "ac0.3" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.3",
            "description" : ""
          },
          "ac0.4" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.4",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Risiko for overfølsomhetsreaksjon",
            "description" : "Klinisk vurdering av tendensen for et individ til å oppleve en skadelig eller uønsket fysiologisk reaksjon ved eksponering eller re-eksponering for en substans.",
            "comment" : "Substanser omfatter men er ikke begrenset til: terapeutiske substanser korrekt administrert ved en passende dose for individet, mat, materiale fra planter eller dyr, eller gift fra insektstikk."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Substans",
            "description" : "Den spesifikke substansen eller substansklassen som setter individet i faresonen for en reaksjonshendelse.",
            "comment" : "Feltet tillater en registrering av enten en spesifikk substans eller en substansklasse. En substans kan være en blanding av enkeltsubstanser, for eksempel et legemiddelprodukt. Det er sterkt anbefalt at \"Substans\" kodes med en terminologi som kan utløse beslutningsstøtte, der det er mulig. For eksempel: FEST, ATC eller SNOMED CT. Fritekst bør bare brukes hvis en hensiktsmessig terminologi ikke er tilgjengelig."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Kommentar",
            "description" : "Ytterligere fritekstbeskrivelse om risikoen for overfølsomhetsreaksjon, som ikke fanges opp i andre felter.",
            "comment" : "For eksempel: Grunnlag for at \"Alvorlighetsgrad\" er satt til \"Høy\", instruksjoner relatert til fremtidige eksponeringer for eller administrasjon av substansen, som administrasjon ved en intensivenhet eller under kortikosteroidbehandling."
          },
          "at0042" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0042",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0047" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Understøttende klinisk informasjon",
            "description" : "Lenke til ytterligere informasjon om symptomer, tegn og funn som finnes andre steder i journalen, inklusiv allergitestrapporter.",
            "comment" : "For eksempel symptomer, undersøkelsesfunn eller diagnoser."
          },
          "at0058" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaksjonsmekanisme",
            "description" : "Identifisering av overfølsomhetsreaksjonens underliggende fysiologiske mekanisme.",
            "comment" : "Immunmediert respons har tradisjonelt blitt ansett som en indikator for eskalering av signifikant fremtidig risiko. Moderne kunnskap tyder på at noen reaksjoner tidligere antatt å være immune faktisk er ikke-immune og likevel innebærer livstruende risiko. I tillegg kan mange antatt ikke-immunologiske reaksjoner faktisk være immunologiske, siden det finnes mangler i vårt diagnostiske apparat som gjør at vi ikke klarer å identifisere mekanismen.\r\n\r\nImmunologiske tester kan gi evidens for identifisering av mekanisme og årsakssubstans, men ingen tester er 100% sensitive eller spesifikke.\r\n\r\nDet erkjennes at klinikere ofte ikke kan identifisere mekanismen for en gitt reaksjon. Dette dataelementet er likevel inkludert fordi det blir brukt i mange eldre systemer."
          },
          "at0059" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0059",
            "text" : "Immunmediert",
            "description" : "Immunmediert reaksjon, inklusive allergiske reaksjoner og hypersensitiviteter."
          },
          "at0060" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0060",
            "text" : "Ikke-immunmediert",
            "description" : "En ikke-immunmediert reaksjon, som kan omfatte pseudoallergiske reaksjoner, bivirkninger, intoleranser eller legemiddeltoksisitet (f.eks gentamicin)."
          },
          "at0062" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Sist oppdatert",
            "description" : "Dato da informasjonen sist ble oppdatert."
          },
          "at0063" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "Verifikasjonsstatus",
            "description" : "Påstand om hvor sikkert det er at individet har en tendens eller framtidig risiko på få en overfølsomhetsreaksjon på den angitte substansen.",
            "comment" : "Beslutningsstøttesystemer vil typisk reagere på statusene \"Ubekreftet\" og \"Bekreftet\", og ignorere \"Avkreftet\". Kliniske systemer kan velge å ikke vise overfølsomhetsreaksjoner som har status \"Avkreftet\" i listen over overfølsomhetsreaksjoner. Imidlertid kan \"Avkreftet\" være nyttig for samstemming av listen over overfølsomhetsreaksjoner, eller ved kommunikasjon mellom systemer. Noen implementasjoner kan velge å gjøre dette elementet obligatorisk. Fritekst-datatypen tillater lokal variasjon ved å gjøre det mulig å legge til andre verdisett i et templat. I disse tilfellene er det anbefalt at verdiene kodes med en terminologi."
          },
          "at0064" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0064",
            "text" : "Ubekreftet",
            "description" : "Tendensen til reaksjon på den angitte substansen har ikke blitt objektivt verifisert."
          },
          "at0065" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0065",
            "text" : "Bekreftet",
            "description" : "Tendensen til reaksjon på den angitte substansen har blitt objektivt verifisert. Dette kan omfatte klinisk evidens fra testing, provokasjonstesting eller observasjon."
          },
          "at0066" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0066",
            "text" : "Avkreftet",
            "description" : "Tendensen til å reagere på den angitte substansen har blitt avkreftet med tilstrekkelig nivå av klinisk sikkerhet til at utsagnet kan invalideres. Dette kan omfatte klinisk evidens fra testing, provokasjonstesting eller observasjon."
          },
          "at0101" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0101",
            "text" : "Alvorlighetsgrad",
            "description" : "En indikasjon på potensialet for kritisk organskade eller livstruende konsekvenser.",
            "comment" : "Dette kan ses på som en vurdering av et \"worst case scenario\". I de fleste kontekster vil \"Lav\" være en standardverdi."
          },
          "at0102" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0102",
            "text" : "Lav",
            "description" : "Eksponering for substansen vil sannsynligvis ikke resultere i kritisk organskade eller livstruende konsekvenser. Fremtidig eksponering for den angitte substansen bør regnes som en relativ kontraindikasjon under ordinære kliniske omstendigheter."
          },
          "at0103" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0103",
            "text" : "Høy",
            "description" : "Eksponering for substansen kan resultere i kritisk organskade eller livstruende konsekvenser. Fremtidig eksponering for den angitte substansen bør regnes som en absolutt kontraindikasjon under ordinære kliniske omstendigheter."
          },
          "at0117" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Debut av siste reaksjon",
            "description" : "Dato og/eller tid da den siste kjente reaksjonshendelsen startet.",
            "comment" : "For eksempel: Den faktiske datoen og/eller tidspunktet for debuten, tidsintervallet debuten inntraff innenfor, individets alder da debuten inntraff, eller tid siden debuten inntraff. Det kan registreres deldatoer ved å bruke datatypen DV_DATE_TIME, for å registrere kun et årstall."
          },
          "at0120" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Kategori",
            "description" : "Kategorien til den angitte substansen.",
            "comment" : "Dette dataelementet er inkludert fordi det brukes i enkelte kliniske systemer. Dataene kan avledes fra substansen dersom man bruker hierarkiske kodesystemer, og er i slike tilfeller overflødig."
          },
          "at0121" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0121",
            "text" : "Mat",
            "description" : "Enhver substans som spises eller drikkes som næring for kroppen, som f.eks. peanøtter eller egg."
          },
          "at0122" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0122",
            "text" : "Legemiddel",
            "description" : "Enhver substans som administreres for å oppnå en fysiologisk effekt."
          },
          "at0123" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0123",
            "text" : "Annet",
            "description" : "Enhver annen substans, inklusive animalsk gift, latex og andre substanser i omgivelsene."
          },
          "at0124" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0124",
            "text" : "Ubestemt",
            "description" : "Umulig å vurdere med tilgjengelig informasjon."
          },
          "at0126" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0126",
            "text" : "Uviss",
            "description" : "Den fysiologiske mekanismen kunne ikke fastslås."
          },
          "at0128" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0128",
            "text" : "Utvidelse",
            "description" : "Ytterligere informasjon som trengs for å kunne registrere lokalt definert innhold eller for å tilpasse til andre referansemodeller/formalismer.",
            "comment" : "For eksempel lokale informasjonsbehov eller ytterligere metadata for å kunne tilpasse til tilsvarende konsepter i FHIR."
          },
          "at0129" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0129",
            "text" : "Sammendrag av reaksjonshendelse",
            "description" : "Detaljert sammendrag om hver enkelt reaksjonshendelse, koblet til eksponering for den angitte substansen."
          },
          "at0130" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "Aktiv/inaktiv status",
            "description" : "Status for hvorvidt risikoen for overfølsomhetsreaksjon er aktiv eller inaktiv."
          },
          "at0131" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0131",
            "text" : "Aktiv",
            "description" : "Individet har ved registreringstidspunktet en risiko for å få en reaksjon på den angitte substansen."
          },
          "at0132" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0132",
            "text" : "Inaktiv",
            "description" : "Individet har ved registreringstidspunktet ikke lenger en risiko for å få en reaksjon på den angitte substansen."
          },
          "at0133" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "Debut av første reaksjon",
            "description" : "Dato og/eller tid da den første kjente reaksjonshendelsen startet.",
            "comment" : "For eksempel: Den faktiske datoen og/eller tidspunktet for debuten, tidsintervallet debuten inntraff innenfor, individets alder da debuten inntraff, eller tid siden debuten inntraff. Det kan registreres deldatoer ved å bruke datatypen DV_DATE_TIME, for å registrere kun et årstall."
          },
          "at0133.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "Debut av første reaksjon",
            "description" : "Dato og/eller tid da den første kjente reaksjonshendelsen startet.",
            "comment" : "For eksempel: Den faktiske datoen og/eller tidspunktet for debuten, tidsintervallet debuten inntraff innenfor, individets alder da debuten inntraff, eller tid siden debuten inntraff. Det kan registreres deldatoer ved å bruke datatypen DV_DATE_TIME, for å registrere kun et årstall."
          },
          "at0120.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Kategori",
            "description" : "Kategorien til den angitte substansen.",
            "comment" : "Dette dataelementet er inkludert fordi det brukes i enkelte kliniske systemer. Dataene kan avledes fra substansen dersom man bruker hierarkiske kodesystemer, og er i slike tilfeller overflødig."
          },
          "at0130.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "Aktiv/inaktiv status",
            "description" : "Status for hvorvidt risikoen for overfølsomhetsreaksjon er aktiv eller inaktiv."
          },
          "at0058.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaksjonsmekanisme",
            "description" : "Identifisering av overfølsomhetsreaksjonens underliggende fysiologiske mekanisme.",
            "comment" : "Immunmediert respons har tradisjonelt blitt ansett som en indikator for eskalering av signifikant fremtidig risiko. Moderne kunnskap tyder på at noen reaksjoner tidligere antatt å være immune faktisk er ikke-immune og likevel innebærer livstruende risiko. I tillegg kan mange antatt ikke-immunologiske reaksjoner faktisk være immunologiske, siden det finnes mangler i vårt diagnostiske apparat som gjør at vi ikke klarer å identifisere mekanismen.\r\n\r\nImmunologiske tester kan gi evidens for identifisering av mekanisme og årsakssubstans, men ingen tester er 100% sensitive eller spesifikke.\r\n\r\nDet erkjennes at klinikere ofte ikke kan identifisere mekanismen for en gitt reaksjon. Dette dataelementet er likevel inkludert fordi det blir brukt i mange eldre systemer."
          },
          "at0047.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Understøttende klinisk informasjon",
            "description" : "Lenke til ytterligere informasjon om symptomer, tegn og funn som finnes andre steder i journalen, inklusiv allergitestrapporter.",
            "comment" : "For eksempel symptomer, undersøkelsesfunn eller diagnoser."
          },
          "at0006.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Kommentar",
            "description" : "Ytterligere fritekstbeskrivelse om risikoen for overfølsomhetsreaksjon, som ikke fanges opp i andre felter.",
            "comment" : "For eksempel: Grunnlag for at \"Alvorlighetsgrad\" er satt til \"Høy\", instruksjoner relatert til fremtidige eksponeringer for eller administrasjon av substansen, som administrasjon ved en intensivenhet eller under kortikosteroidbehandling."
          },
          "at0063.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "Verifikasjonsstatus",
            "description" : "Påstand om hvor sikkert det er at individet har en tendens eller framtidig risiko på få en overfølsomhetsreaksjon på den angitte substansen.",
            "comment" : "Beslutningsstøttesystemer vil typisk reagere på statusene \"Ubekreftet\" og \"Bekreftet\", og ignorere \"Avkreftet\". Kliniske systemer kan velge å ikke vise overfølsomhetsreaksjoner som har status \"Avkreftet\" i listen over overfølsomhetsreaksjoner. Imidlertid kan \"Avkreftet\" være nyttig for samstemming av listen over overfølsomhetsreaksjoner, eller ved kommunikasjon mellom systemer. Noen implementasjoner kan velge å gjøre dette elementet obligatorisk. Fritekst-datatypen tillater lokal variasjon ved å gjøre det mulig å legge til andre verdisett i et templat. I disse tilfellene er det anbefalt at verdiene kodes med en terminologi."
          },
          "at0062.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Sist oppdatert",
            "description" : "Dato da informasjonen sist ble oppdatert."
          },
          "at0117.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Debut av siste reaksjon",
            "description" : "Dato og/eller tid da den siste kjente reaksjonshendelsen startet.",
            "comment" : "For eksempel: Den faktiske datoen og/eller tidspunktet for debuten, tidsintervallet debuten inntraff innenfor, individets alder da debuten inntraff, eller tid siden debuten inntraff. Det kan registreres deldatoer ved å bruke datatypen DV_DATE_TIME, for å registrere kun et årstall."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Risiko for overfølsomhetsreaksjon",
            "description" : "Klinisk vurdering av tendensen for et individ til å oppleve en skadelig eller uønsket fysiologisk reaksjon ved eksponering eller re-eksponering for en substans.",
            "comment" : "Substanser omfatter men er ikke begrenset til: terapeutiske substanser korrekt administrert ved en passende dose for individet, mat, materiale fra planter eller dyr, eller gift fra insektstikk."
          }
        },
        "de" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "ac0.2" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.2",
            "description" : ""
          },
          "ac0.3" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.3",
            "description" : ""
          },
          "ac0.4" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.4",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Nebenwirkungsrisiko",
            "description" : "Klinische Beurteilung der Neigung einer Person, eine schädliche oder unerwünschte physiologische Reaktion zu erfahren, wenn sie einer Substanz ausgesetzt oder erneut ausgesetzt wird.",
            "comment" : "Zu den Substanzen gehören, ohne darauf beschränkt zu sein: eine therapeutische Substanz, die korrekt in einer für die Person geeigneten Dosierung verabreicht wird; Lebensmittel; pflanzliche oder tierische Rohstoffe; oder Gift von Insektenstichen.",
            "source" : "openEHR, FHIR"
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Substanz",
            "description" : "Identifizierung einer Substanz oder Substanzklasse, von der angenommen wird, dass sie die Person einem Risiko für ein Auftreten von unerwünschter Reaktion aussetzt.",
            "comment" : "Sowohl ein einzelner Stoff als auch eine Stoffklasse sind gültige Einträge in „Stoff“. Ein Stoff kann eine Verbindung einfacherer Stoffe sein, beispielsweise ein Arzneimittel. Es wird dringend empfohlen, die „Substanz“ nach Möglichkeit mit einer Terminologie zu kodieren, die eine Entscheidungsunterstützung auslösen kann. Zum Beispiel: Snomed CT, DM+D, RxNorm, NDFRT, ATC, New Zealand Universal List of Medicines und Australian Medicines Terminology. Die Freitexteingabe sollte nur dann genutzt werden, wenn keine entsprechende Terminologie verfügbar ist.",
            "source" : "openEHR, FHIR, DAM"
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Kommentar",
            "description" : "Zusätzliche Beschreibung ber die Tendenz zur Nebenwirkung, die in anderen Bereichen nicht erfasst wurde.",
            "comment" : "Zum Beispiel: einschließlich des Grundes für die Kennzeichnung des Risikos mit einer hohen \"Gefährlichkeit\" und Anweisungen in Bezug auf die zukünftige Exposition oder Verabreichung der Substanz, wie zum Beispiel die Verabreichung auf einer Intensivstation oder unter Kortikosteroidabdeckung.",
            "source" : "openEHR"
          },
          "at0042" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0042",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0047" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Unterstützung von klinischen Informationen",
            "description" : "Link zu weiteren Informationen über die Präsentation und den Befunden, die an anderer Stelle in der Gesundheitsakte vorhanden sind, einschließlich Allergietestberichten.",
            "comment" : "Zum Beispiel Darstellung von Symptomen, Untersuchungsbefunden, Diagnose etc.",
            "source" : "FHIR, openEHR, DAM"
          },
          "at0058" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaktionsmechanismus",
            "description" : "Identifizierung des zugrunde liegenden physiologischen Mechanismus für die Nebenwirkung.",
            "comment" : "Immunvermittelte Reaktionen wurden üblicherweise als Indikator für die Eskalation eines signifikanten künftigen Risikos betrachtet. Aktuelles Wissen führt zur Annahme, dass einige bisher als immun betrachteten Reaktionen, tatsächlich nicht immun sind und dennoch ein lebensbedrohliches Risiko bergen.\r\n\r\nImmunologische Tests können Belege für den Mechanismus und die verursachende Substanz liefern, aber keine Tests sind 100% sensitiv oder spezifisch für eine Sensitivität.\r\n\r\nEs wird anerkannt, dass die meisten Kliniker den Mechanismus einer bestimmten Reaktion NICHT unterscheiden können. Dieses Datenelement ist jedoch enthalten, da viele veraltete Systeme diese Eigenschaft erfasst haben.",
            "source" : "FHIR, DAM"
          },
          "at0059" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0059",
            "text" : "Immunvermittelt",
            "description" : "Immunvermittelte Reaktion, einschließlich allergischer Reaktionen und Überempfindlichkeit."
          },
          "at0060" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0060",
            "text" : "Nicht-Immunvermittelt",
            "description" : "Eine nicht immunvermittelte Reaktion, die pseudoallergische Reaktionen, Nebenwirkungen, Unverträglichkeiten und Arzneimitteltoxizitäten (z. B. gegen Gentamicin) umfassen kann."
          },
          "at0062" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Letzte Aktualisierung",
            "description" : "Datum, an dem die Neigung zur Reaktion oder der Fall einer Reaktion aktualisiert wurde.",
            "source" : "openEHR, FHIR, DAM"
          },
          "at0063" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "Verifizierungsstatus",
            "description" : "Aussage zur Sicherheit über die Tendenz oder über das potenzielle zukünftige Risiko der identifizierten „Substanz“, eine Reaktion auszulösen.",
            "comment" : "Die Entscheidungsunterstützung löst in der Regel Warnungen für „Unbestätigt“ und „Bestätigt“ aus und ignoriert eine „Widerlegt“-Reaktion. Klinische Systeme können sich dafür entscheiden, Einträge zu Nebenwirkungen mit dem Status „Widerlegt“ in der Liste der Nebenwirkungen nicht anzuzeigen. „Widerlegt“ kann jedoch für den Abgleich der Nebenwirkungsliste oder bei der Kommunikation zwischen Systemen nützlich sein. Einige Implementierungen entscheiden sich möglicherweise dafür, dieses Feld obligatorisch zu machen. Der Freitext-Datentyp ermöglicht lokale Variationen, indem er die Anwendung anderer Wertesätze auf dieses Datenelement in einer Vorlage ermöglicht. In dieser Situation wird empfohlen, Werte mithilfe einer Terminologie zu codieren.",
            "source" : "FHIR, DAM"
          },
          "at0064" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0064",
            "text" : "Nicht bestätigt",
            "description" : "*The propensity for a reaction to the identified 'Substance' has not been objectively verified. (en)"
          },
          "at0065" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0065",
            "text" : "Bestätigt",
            "description" : "*The propensity for a reaction to the identified 'Substance' has been objectively verified. This may include clinical evidence by testing, re-challenge or observation. (en)"
          },
          "at0066" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0066",
            "text" : "Widerlegt",
            "description" : "*A propensity for a reaction to the identified 'Substance' has been disputed or disproven with a sufficient level of clinical certainty to justify invalidating the assertion. This may include clinical evidence by testing, re-challenge or observation. (en)"
          },
          "at0101" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0101",
            "text" : "Kritikalität",
            "description" : "Ein Hinweis auf das Potenzial für kritische Systemorganschäden oder lebensbedrohliche Folgen.",
            "comment" : "Dies kann als vorausschauende Beurteilung eines „Worst-Case-Szenarios“ angesehen werden. In den meisten Zusammenhängen wird „Niedrig“ als Standardwert angesehen.",
            "source" : "DAM, openEHR"
          },
          "at0102" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0102",
            "text" : "Niedrig",
            "description" : "Die Exposition gegenüber Substanzen führt wahrscheinlich nicht zu kritischen Schäden von Systemorganen oder zu lebensbedrohlichen Folgen. Eine künftige Exposition gegenüber der identifizierten „Substanz“ sollte unter normalen klinischen Umständen als relative Kontraindikation angesehen werden."
          },
          "at0103" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0103",
            "text" : "Hoch",
            "description" : "Die Exposition gegenüber Substanzen kann zu kritischen Schäden von Systemorganen oder zu lebensbedrohlichen Folgen führen. Eine künftige Exposition gegenüber der identifizierten „Substanz“ sollte unter normalen klinischen Umständen als absolute Kontraindikation angesehen werden."
          },
          "at0117" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Beginn der letzten Reaktion",
            "description" : "Datum und/ oder Uhrzeit des Beginns des letzten bekannten Auftretens eines Reaktionsereignisses.",
            "comment" : "Zum Beispiel: das tatsächliche Datum und/oder die tatsächliche Uhrzeit des Beginns; das Zeitintervall, in dem der Beginn erfolgte; das Alter der Person zum Zeitpunkt des Ausbruchs; oder die Zeitspanne seit dem Ausbruch. Bei Verwendung des Datentyps DV_DATE_TIME ist ein Teildatum gültig, um nur ein Jahr aufzuzeichnen.",
            "source" : "IMH"
          },
          "at0120" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Kategorie",
            "description" : "Kategorie der identifizierten \"Substanz\".",
            "comment" : "Dieses Datenelement wurde aufgenommen, da es derzeit in einigen klinischen Systemen erfasst wird. Diese Daten können von der Substanz abgeleitet werden, in der Codierungssysteme verwendet werden und sind in dieser Situation effektiv redundant."
          },
          "at0121" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0121",
            "text" : "Lebensmittel",
            "description" : "Jede Substanz, die konsumiert wird, um dem Körper Nahrung zu liefern, wie Erdnuss oder Ei."
          },
          "at0122" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0122",
            "text" : "Medikament",
            "description" : "Jede Substanz, die verabreicht wird, um eine physiologische Wirkung zu erzielen."
          },
          "at0123" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0123",
            "text" : "Andere",
            "description" : "Alle anderen auftretende Substanzen, einschließlich Gift, Latex und anderer Substanzen aus der Umwelt."
          },
          "at0124" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0124",
            "text" : "Unbestimmt",
            "description" : "Eine Bewertung ist mit verfügbaren Informationen nicht möglich."
          },
          "at0126" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0126",
            "text" : "Unbestimmt",
            "description" : "Der physiologische Mechanismus konnte nicht bestimmt werden."
          },
          "at0128" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0128",
            "text" : "Erweiterung",
            "description" : "Zusätzliche Informationen zur Erfassung lokaler Inhalte oder Anpassung an andere Referenzmodelle/Formalismen.",
            "comment" : "Zum Beispiel: lokale Informationsanforderungen oder zusätzliche Metadaten zur Anpassung an FHIR-Äquivalente."
          },
          "at0129" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0129",
            "text" : "Zusammenfassung des Reaktionsereignis",
            "description" : "Zusammenfassende Details zu jedem Nebenwirkungsereignis im Zusammenhang mit der Exposition gegenüber dem identifizierten „Stoff“."
          },
          "at0130" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "Aktiver/inaktiver Status",
            "description" : "Status darüber, ob die Risikoerklärung zu Nebenwirkungen aktiv oder inaktiv ist."
          },
          "at0131" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0131",
            "text" : "Aktiv",
            "description" : "Bei der Person kommt es derzeit zu einer Reaktion auf die identifizierte Substanz oder es besteht die Gefahr einer solchen."
          },
          "at0132" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0132",
            "text" : "Inaktiv",
            "description" : "Für den Probanden besteht kein Risiko mehr, dass er auf den identifizierten Stoff reagiert."
          },
          "at0133" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "Beginn der ersten Reaktion",
            "description" : "Der Beginn des ersten bekannten Auftretens eines Reaktionsereignisses.",
            "comment" : "Zum Beispiel: das tatsächliche Datum und/oder die tatsächliche Uhrzeit des Beginns; das Zeitintervall, in dem der Beginn erfolgte; das Alter der Person zum Zeitpunkt des Ausbruchs; oder die Zeitspanne seit dem Ausbruch. Bei Verwendung des Datentyps DV_DATE_TIME ist ein Teildatum gültig, um nur ein Jahr aufzuzeichnen."
          },
          "at0133.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "Beginn der ersten Reaktion",
            "description" : "Der Beginn des ersten bekannten Auftretens eines Reaktionsereignisses.",
            "comment" : "Zum Beispiel: das tatsächliche Datum und/oder die tatsächliche Uhrzeit des Beginns; das Zeitintervall, in dem der Beginn erfolgte; das Alter der Person zum Zeitpunkt des Ausbruchs; oder die Zeitspanne seit dem Ausbruch. Bei Verwendung des Datentyps DV_DATE_TIME ist ein Teildatum gültig, um nur ein Jahr aufzuzeichnen."
          },
          "at0120.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Kategorie",
            "description" : "Kategorie der identifizierten \"Substanz\".",
            "comment" : "Dieses Datenelement wurde aufgenommen, da es derzeit in einigen klinischen Systemen erfasst wird. Diese Daten können von der Substanz abgeleitet werden, in der Codierungssysteme verwendet werden und sind in dieser Situation effektiv redundant."
          },
          "at0130.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "Aktiver/inaktiver Status",
            "description" : "Status darüber, ob die Risikoerklärung zu Nebenwirkungen aktiv oder inaktiv ist."
          },
          "at0058.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaktionsmechanismus",
            "description" : "Identifizierung des zugrunde liegenden physiologischen Mechanismus für die Nebenwirkung.",
            "comment" : "Immunvermittelte Reaktionen wurden üblicherweise als Indikator für die Eskalation eines signifikanten künftigen Risikos betrachtet. Aktuelles Wissen führt zur Annahme, dass einige bisher als immun betrachteten Reaktionen, tatsächlich nicht immun sind und dennoch ein lebensbedrohliches Risiko bergen.\r\n\r\nImmunologische Tests können Belege für den Mechanismus und die verursachende Substanz liefern, aber keine Tests sind 100% sensitiv oder spezifisch für eine Sensitivität.\r\n\r\nEs wird anerkannt, dass die meisten Kliniker den Mechanismus einer bestimmten Reaktion NICHT unterscheiden können. Dieses Datenelement ist jedoch enthalten, da viele veraltete Systeme diese Eigenschaft erfasst haben.",
            "source" : "FHIR, DAM"
          },
          "at0047.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Unterstützung von klinischen Informationen",
            "description" : "Link zu weiteren Informationen über die Präsentation und den Befunden, die an anderer Stelle in der Gesundheitsakte vorhanden sind, einschließlich Allergietestberichten.",
            "comment" : "Zum Beispiel Darstellung von Symptomen, Untersuchungsbefunden, Diagnose etc.",
            "source" : "FHIR, openEHR, DAM"
          },
          "at0006.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Kommentar",
            "description" : "Zusätzliche Beschreibung ber die Tendenz zur Nebenwirkung, die in anderen Bereichen nicht erfasst wurde.",
            "comment" : "Zum Beispiel: einschließlich des Grundes für die Kennzeichnung des Risikos mit einer hohen \"Gefährlichkeit\" und Anweisungen in Bezug auf die zukünftige Exposition oder Verabreichung der Substanz, wie zum Beispiel die Verabreichung auf einer Intensivstation oder unter Kortikosteroidabdeckung.",
            "source" : "openEHR"
          },
          "at0063.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "Verifizierungsstatus",
            "description" : "Aussage zur Sicherheit über die Tendenz oder über das potenzielle zukünftige Risiko der identifizierten „Substanz“, eine Reaktion auszulösen.",
            "comment" : "Die Entscheidungsunterstützung löst in der Regel Warnungen für „Unbestätigt“ und „Bestätigt“ aus und ignoriert eine „Widerlegt“-Reaktion. Klinische Systeme können sich dafür entscheiden, Einträge zu Nebenwirkungen mit dem Status „Widerlegt“ in der Liste der Nebenwirkungen nicht anzuzeigen. „Widerlegt“ kann jedoch für den Abgleich der Nebenwirkungsliste oder bei der Kommunikation zwischen Systemen nützlich sein. Einige Implementierungen entscheiden sich möglicherweise dafür, dieses Feld obligatorisch zu machen. Der Freitext-Datentyp ermöglicht lokale Variationen, indem er die Anwendung anderer Wertesätze auf dieses Datenelement in einer Vorlage ermöglicht. In dieser Situation wird empfohlen, Werte mithilfe einer Terminologie zu codieren.",
            "source" : "FHIR, DAM"
          },
          "at0062.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Letzte Aktualisierung",
            "description" : "Datum, an dem die Neigung zur Reaktion oder der Fall einer Reaktion aktualisiert wurde.",
            "source" : "openEHR, FHIR, DAM"
          },
          "at0117.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Beginn der letzten Reaktion",
            "description" : "Datum und/ oder Uhrzeit des Beginns des letzten bekannten Auftretens eines Reaktionsereignisses.",
            "comment" : "Zum Beispiel: das tatsächliche Datum und/oder die tatsächliche Uhrzeit des Beginns; das Zeitintervall, in dem der Beginn erfolgte; das Alter der Person zum Zeitpunkt des Ausbruchs; oder die Zeitspanne seit dem Ausbruch. Bei Verwendung des Datentyps DV_DATE_TIME ist ein Teildatum gültig, um nur ein Jahr aufzuzeichnen.",
            "source" : "IMH"
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Nebenwirkungsrisiko",
            "description" : "Klinische Beurteilung der Neigung einer Person, eine schädliche oder unerwünschte physiologische Reaktion zu erfahren, wenn sie einer Substanz ausgesetzt oder erneut ausgesetzt wird.",
            "comment" : "Zu den Substanzen gehören, ohne darauf beschränkt zu sein: eine therapeutische Substanz, die korrekt in einer für die Person geeigneten Dosierung verabreicht wird; Lebensmittel; pflanzliche oder tierische Rohstoffe; oder Gift von Insektenstichen.",
            "source" : "openEHR, FHIR"
          }
        },
        "sv" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "ac0.2" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.2",
            "description" : ""
          },
          "ac0.3" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.3",
            "description" : ""
          },
          "ac0.4" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.4",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Biverkningsrisk",
            "description" : "*Clinical assessment of the propensity for an individual to experience a harmful or undesirable physiological response if exposed, or re-exposed, to a substance. (en)",
            "comment" : "Dessa substanser inkluderar bland annat: ett terapeutiskt ämne som administreras korrekt i en lämplig dos för individen; mat; material härrörande från växter eller djur; eller gift från insektsstick."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Substans",
            "description" : "Identifiering av ett ämne eller ämnesklass som anses utgöra en risk för en enskild reaktion.",
            "comment" : "*Both an individual substance and a substance class are valid entries in 'Substance'. A substance may be a compound of simpler substances, for example a medicinal product. It is strongly recommended that the 'Substance' is coded with a terminology capable of triggering decision support, where possible. For example: Snomed CT, DM+D, RxNorm, NDFRT, ATC, New Zealand Universal List of Medicines and Australian Medicines Terminology. Free text entry should only be used if there is no appropriate terminology available. (en)",
            "source" : "openEHR,FHIR,DAM"
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Kommentar",
            "description" : "Kommentarer avseende benägenheten för biverkningen som inte beskrivs i övriga fält.",
            "comment" : "Exempelvis skäl för markering av \"Kritisk nivå\" som \"Hög risk\"; och instruktioner relaterade till framtida exponering eller administrering av ämnet, såsom administrering inom en intensivvårdsavdelning eller under kortikosteroidskydd.",
            "source" : "openEHR"
          },
          "at0042" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0042",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0047" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Stöd till information i hälsojournal",
            "description" : "Koppling till ytterligare information om presentationen och fynd lokaliserad på annan plats i hälsojournalen, inklusive allergitestrapporter.",
            "comment" : "*For example, presenting symptoms, examination findings, diagnosis etc. (en)",
            "source" : "FHIR, openEHR, DAM"
          },
          "at0058" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaktionsmekanism",
            "description" : "Identifiering av den underliggande fysiologiska mekanismen för biverkningen.",
            "comment" : "Immunmedierad respons har traditionellt betraktats som en indikator för upptrappning av framtida risk. Dagens forskning tyder på att vissa reaktioner som man tidigare trodde var immuna i stället är icke-immuna och bär livshotande risk.\r\n\r\nImmunologiska tester kan ge bevis för mekanismen och orsakssubstansen. Inga tester kan dock erhålla 100% sensitivitet eller specificitet.\r\n\r\nAtt de flesta kliniker INTE kommer att kunna skilja mekanismen för en specifik reaktion är välkänt. Detta dataelement ingår dock då många äldre system har fångat upp detta attribut.",
            "source" : "FHIR, DAM"
          },
          "at0059" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0059",
            "text" : "Immunmedierad",
            "description" : "Immunmedierad reaktion, inklusive allergiska reaktioner och överkänslighet."
          },
          "at0060" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0060",
            "text" : "Icke immunmedierad",
            "description" : "En icke immunförmedlad reaktion, vilken kan inkludera pseudoallergiska reaktioner, biverkningar, intoleranser, läkemedeltoxicitet (exempelvis gentamicin)."
          },
          "at0062" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Senast uppdaterad",
            "description" : "Datum då benägenheten eller reaktionshändelsen uppdaterades."
          },
          "at0063" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "*Verification status (en)",
            "description" : "Angivelse om sannolikheten att det identifierade ämnet som orsakar en reaktion även medför potentiella risker.",
            "comment" : "*Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology. (en)",
            "source" : "FHIR, DAM"
          },
          "at0064" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0064",
            "text" : "*Unconfirmed (en)",
            "description" : "*The propensity for a reaction to the identified 'Substance' has not been objectively verified. (en)"
          },
          "at0065" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0065",
            "text" : "Bekräftat",
            "description" : "*The propensity for a reaction to the identified 'Substance' has been objectively verified. This may include clinical evidence by testing, re-challenge or observation. (en)"
          },
          "at0066" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0066",
            "text" : "Vederlagt",
            "description" : "*A propensity for a reaction to the identified 'Substance' has been disputed or disproven with a sufficient level of clinical certainty to justify invalidating the assertion. This may include clinical evidence by testing, re-challenge or observation. (en)"
          },
          "at0101" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0101",
            "text" : "Kritisk nivå",
            "description" : "En indikation på potentialen för kritiska organskador eller livshotande konsekvenser.",
            "comment" : "*This can be regarded as a predictive judgement of a 'worst case scenario'. In most contexts 'Low' would be regarded as the default value. (en)",
            "source" : "DAM, openEHR"
          },
          "at0102" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0102",
            "text" : "Låg",
            "description" : "Exponering för ämnet som sannolikt inte kan leda till kritiska organskador eller livshotande konsekvenser. Framtida exponering för det identifierade ämnet bör betraktas som en relativt kontraindikation under normala kliniska omständigheter."
          },
          "at0103" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0103",
            "text" : "Hög",
            "description" : "Exponering för ämnet kan leda till kritiska organskador eller livshotande konsekvenser. Framtida exponering för det identifierade ämnet bör betraktas som en absolut kontraindikation under normala kliniska omständigheter."
          },
          "at0117" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Debut av sista reaktionen",
            "description" : "Datum och/eller tid då den senast kända förekomsten av en reaktionshändelse började.",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)",
            "source" : "IMH"
          },
          "at0120" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Kategori",
            "description" : "Kategori för identifierad \"Substans\".",
            "comment" : "Detta dataelement har inkluderats då det för närvarande registreras i vissa kliniska system. Denna data kan härledas från substansen där kodningssystem används, och är därför överflödigt i sådana situationer."
          },
          "at0121" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0121",
            "text" : "Mat",
            "description" : "Alla ämnen som konsumeras för att ge kroppen näringsstöd, såsom jordnötter eller ägg."
          },
          "at0122" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0122",
            "text" : "Läkemedel",
            "description" : "Alla substanser som administreras för att uppnå en fysiologisk effekt."
          },
          "at0123" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0123",
            "text" : "Annat",
            "description" : "Alla andra ämnen som påträffas inklusive gift, latex och andra miljöämnen."
          },
          "at0124" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0124",
            "text" : "Obestämbar",
            "description" : "Det går inte att bedöma med tillgänglig information."
          },
          "at0126" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0126",
            "text" : "Obestämd",
            "description" : "Den fysiologiska mekanismen kunde inte bestämmas."
          },
          "at0128" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0128",
            "text" : "Tilläggsinformation",
            "description" : "Plats för att infoga tilläggsinformation som krävs för lokala anpassningar eller anpassning till andra referensmodeller eller formella krav.",
            "comment" : "*For example: local information requirements or additional metadata to align with FHIR equivalents. (en)"
          },
          "at0129" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0129",
            "text" : "*Reaction event summary (en)",
            "description" : "*Summary details about each adverse reaction event linked to exposure to the identified 'Substance'. (en)"
          },
          "at0130" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "*Active/inactive status (en)",
            "description" : "*Status about whether the adverse reaction risk statement is active or inactive. (en)"
          },
          "at0131" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0131",
            "text" : "*Active (en)",
            "description" : "*The subject is currently experiencing, or is at risk of, a reaction to the identified substance. (en)"
          },
          "at0132" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0132",
            "text" : "*Inactive (en)",
            "description" : "*The subject is no longer at risk of a reaction to the identified substance. (en)"
          },
          "at0133" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "*Onset of first reaction (en)",
            "description" : "*The onset of the first known occurrence of a reaction event. (en)",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)"
          },
          "at0133.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0133",
            "text" : "*Onset of first reaction (en)",
            "description" : "*The onset of the first known occurrence of a reaction event. (en)",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)"
          },
          "at0120.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0120",
            "text" : "Kategori",
            "description" : "Kategori för identifierad \"Substans\".",
            "comment" : "Detta dataelement har inkluderats då det för närvarande registreras i vissa kliniska system. Denna data kan härledas från substansen där kodningssystem används, och är därför överflödigt i sådana situationer."
          },
          "at0130.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0130",
            "text" : "*Active/inactive status (en)",
            "description" : "*Status about whether the adverse reaction risk statement is active or inactive. (en)"
          },
          "at0058.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0058",
            "text" : "Reaktionsmekanism",
            "description" : "Identifiering av den underliggande fysiologiska mekanismen för biverkningen.",
            "comment" : "Immunmedierad respons har traditionellt betraktats som en indikator för upptrappning av framtida risk. Dagens forskning tyder på att vissa reaktioner som man tidigare trodde var immuna i stället är icke-immuna och bär livshotande risk.\r\n\r\nImmunologiska tester kan ge bevis för mekanismen och orsakssubstansen. Inga tester kan dock erhålla 100% sensitivitet eller specificitet.\r\n\r\nAtt de flesta kliniker INTE kommer att kunna skilja mekanismen för en specifik reaktion är välkänt. Detta dataelement ingår dock då många äldre system har fångat upp detta attribut.",
            "source" : "FHIR, DAM"
          },
          "at0047.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0047",
            "text" : "Stöd till information i hälsojournal",
            "description" : "Koppling till ytterligare information om presentationen och fynd lokaliserad på annan plats i hälsojournalen, inklusive allergitestrapporter.",
            "comment" : "*For example, presenting symptoms, examination findings, diagnosis etc. (en)",
            "source" : "FHIR, openEHR, DAM"
          },
          "at0006.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Kommentar",
            "description" : "Kommentarer avseende benägenheten för biverkningen som inte beskrivs i övriga fält.",
            "comment" : "Exempelvis skäl för markering av \"Kritisk nivå\" som \"Hög risk\"; och instruktioner relaterade till framtida exponering eller administrering av ämnet, såsom administrering inom en intensivvårdsavdelning eller under kortikosteroidskydd.",
            "source" : "openEHR"
          },
          "at0063.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0063",
            "text" : "*Verification status (en)",
            "description" : "Angivelse om sannolikheten att det identifierade ämnet som orsakar en reaktion även medför potentiella risker.",
            "comment" : "*Decision support would typically raise alerts for 'Unconfirmed' and 'Confirmed', and ignore a 'Refuted' reaction. Clinical systems may choose not to display Adverse reaction entries with a 'Refuted' status in the Adverse Reaction List. However, 'Refuted' may be useful for reconciliation of the adverse reaction list or when communicating between systems. Some implementations may choose to make this field mandatory. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology. (en)",
            "source" : "FHIR, DAM"
          },
          "at0062.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0062",
            "text" : "Senast uppdaterad",
            "description" : "Datum då benägenheten eller reaktionshändelsen uppdaterades."
          },
          "at0117.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0117",
            "text" : "Debut av sista reaktionen",
            "description" : "Datum och/eller tid då den senast kända förekomsten av en reaktionshändelse började.",
            "comment" : "*For example: the actual date and/or time of onset; the interval of time during which the onset occurred; the age of the individual at the time of the onset; or the duration of time since the onset occurred. A partial date is valid, using the DV_DATE_TIME data type, to record only a year. (en)",
            "source" : "IMH"
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Biverkningsrisk",
            "description" : "*Clinical assessment of the propensity for an individual to experience a harmful or undesirable physiological response if exposed, or re-exposed, to a substance. (en)",
            "comment" : "Dessa substanser inkluderar bland annat: ett terapeutiskt ämne som administreras korrekt i en lämplig dos för individen; mat; material härrörande från växter eller djur; eller gift från insektsstick."
          }
        }
      },
      "termBindings" : { },
      "terminologyExtracts" : { },
      "valueSets" : {
        "ac0.1" : {
          "@type" : "VALUE_SET",
          "id" : "ac0.1",
          "members" : [ "at0064", "at0065", "at0066" ]
        },
        "ac0.2" : {
          "@type" : "VALUE_SET",
          "id" : "ac0.2",
          "members" : [ "at0131", "at0132" ]
        },
        "ac0.3" : {
          "@type" : "VALUE_SET",
          "id" : "ac0.3",
          "members" : [ "at0121", "at0122", "at0123" ]
        },
        "ac0.4" : {
          "@type" : "VALUE_SET",
          "id" : "ac0.4",
          "members" : [ "at0059", "at0060", "at0126" ]
        }
      }
    },
    "adlVersion" : "1.4",
    "buildUid" : "63592b37-306a-4201-a529-181128ace219",
    "rmName" : "openehr",
    "rmRelease" : "1.1.0",
    "generated" : true,
    "otherMetaData" : { },
    "originalLanguage" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "en"
    },
    "translations" : [ {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "de"
      },
      "author" : {
        "name" : "Natalia Strauch, Darin Leonhardt",
        "organisation" : "Medizinische Hochschule Hannover, PLRI",
        "email" : "Strauch.Natalia@mh-hannover.de, leonhardt.darin@mh-hannover.de"
      },
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "sv"
      },
      "author" : {
        "name" : "Emma Malm",
        "organisation" : "Karolinska Universitetssjukhuset",
        "email" : "emma.malm@cambio.se"
      },
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "nb"
      },
      "author" : {
        "name" : "Silje Ljosland Bakke",
        "organisation" : "Helse Vest IKT AS",
        "email" : "silje.ljosland.bakke@helse-vest-ikt.no"
      },
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "pt-br"
      },
      "author" : {
        "name" : "Osmeire Chamelette Sanzovo",
        "organisation" : "Hospital Sírio Libanês",
        "email" : "osmeire.acsanzovo@hsl.org.br"
      },
      "otherDetails" : { }
    } ]
  }, {
    "@type" : "TEMPLATE_OVERLAY",
    "uid" : "bfcf1cd4-43bb-47ed-a766-d91256da9104",
    "description" : {
      "@type" : "RESOURCE_DESCRIPTION",
      "originalAuthor" : { },
      "otherContributors" : [ ],
      "ipAcknowledgements" : { },
      "references" : { },
      "conversionDetails" : { },
      "otherDetails" : {
        "PARENT:MD5-CAM-1.0.1" : "1F847D0C7A85E138BBBDEA568702B601"
      },
      "details" : {
        "de" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "de"
          },
          "keywords" : [ ],
          "copyright" : "© openEHR Foundation",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "sv" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "sv"
          },
          "purpose" : "Används för att dokumentera ett tillstånd eller status hos en individ som är kliniskt signifikant och unik eller idiosynkratisk för den här individen, och anses vara vital information i samband med beslut om behandling.",
          "keywords" : [ "Försiktighet", "Förhindra", "Avvikande händelse", "Förebygga", "Försiktighet", "Uppmärksamhet", "Varning" ],
          "use" : "Används för att dokumentera ett tillstånd eller status hos en individ som är kliniskt signifikant och unik eller idiosynkratisk för den här individen, och anses vara vital information i samband med beslut om behandling.\r\n\r\nDen här arketypen bör betraktas som en kritisk arketyp för kliniska beslutsstödssystem när det ska testa relevanta terapeutiska försiktighetsåtgärder i samband med att en kliniker inleder en ny klinisk intervention för en individ.\r\n\r\nExempel på tillstånd som berättigar skapandet av en försiktighetsåtgärder kan vara:\r\n- Immunosupprimerad eller genomgår immunosupprimerande behandling - kopplad till en läkemedelsordination för cytostatika eller steroider, eller diagnosen leukemi\r\n- Njursvikt - kopplad till njurfunktionstest eller formell diagnos av njursvikt eller båda\r\n- Väntar på organtransplantation\r\n- Genomgår behandling som strålbehandling eller dialys\r\n- Organtransplanterad eller metallimplantat in situ\r\n- Pågående utredning eller uppföljning av misstänkt eller verifierad malign sjukdom\r\n- Deltagande i läkemedelsprövning; eller\r\n- Använder blodförtunnande läkemedel\r\n",
          "misuse" : "*Not to be used to record a clinical intervention (including, but not limited to, use of a treatment or performance of a test or procedure) that should not be carried out due to the likelihood, or possibility, of harm being caused to an individual. Use the EVALUATION.contraindication for this purpose.\r\n\r\nNot to be used to record decisions about limitations on the individuals care or future interventions or the individuals preferences of future medical treatment and care. Use EVALUATION.advance_intervention_decisions and EVALUATION.advance_care_directive respectively for this purpose.(en)",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "es-ar" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "es-ar"
          },
          "purpose" : "El registro de una condición o estado del individuo que es clínicamente significativa y única o idiosincrática para con este individuo, y que se considera información vital al momento de la toma de decisiones.",
          "keywords" : [ "precaución", "prevenir", "evitar", "evento adverso", "prevención", "precaución", "advertencia" ],
          "use" : "Utilizado para el registro de una condición o estado del individuo que es clínicamente significativa y única o idiosincrática para con este individuo, y que se considera información vital al momento de la toma de decisiones.\r\n\r\nEste arquetipo debe ser considerado crítico por parte de cualquier sistema de apoyo a la decisión clínica y para cualquier precaución terapéuticamente relevante cuando un médico comienza una nueva intervención clínica para con un individuo.\r\n\r\nLos ejemplos de afecciones que ameritan la creación de una precaución incluyen, pero no se limitan a:\r\n- estado de inmunosupresión o terapia inmunosupresora asociada a una orden de medicamento para quimioterapia o esteroides, o diagnóstico de leucemia;\r\n- fallo renal, asociado a pruebas de función renal y/o el diagnóstico formal de fallo renal;\r\n- en espera de trasplante de órgano;\r\n- bajo tratamiento radiante o diálisis;\r\n- trasplantado de órgano o sujeto de implante metálico;\r\n- bajo estudio o bajo seguimiento de enfermedad maligna presuntiva o confirmada;\r\n- participante de ensayo farmacológico;\r\n- anticoagulado.",
          "misuse" : "*Not to be used to record a clinical intervention (including, but not limited to, use of a treatment or performance of a test or procedure) that should not be carried out due to the likelihood, or possibility, of harm being caused to an individual. Use the EVALUATION.contraindication for this purpose.\r\n\r\nNot to be used to record decisions about limitations on the individuals care or future interventions or the individuals preferences of future medical treatment and care. Use EVALUATION.advance_intervention_decisions and EVALUATION.advance_care_directive respectively for this purpose. (en)",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "nb" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "nb"
          },
          "purpose" : "For å registrere en klinisk tilstand eller status som er unik eller særegen for et individ, og som regnes som viktig informasjon i forbindelse med beslutninger om behandling.",
          "keywords" : [ "forsiktighetshensyn", "forhindre", "unngå", "uønsket hendelse", "forebygging", "forsiktighet", "advarsel", "varsel" ],
          "use" : "Brukes for å registrere en klinisk tilstand eller status som er unik eller særegen for et individ, og som regnes som viktig informasjon i forbindelse med beslutning om behandling.\r\n\r\nDenne arketypen bør regnes som en viktig arketype for beslutningsstøttesystemer i forbindelse med forordning av nye kliniske intervensjoner.\r\n\r\nEksempler på tilstander som kan være grunnlag for å registrere forholdsregler kan være:\r\n- Immunhemmende/-modulerende behandling - knyttet til en ordinasjon av kjemoterapi eller steroider, eller en leukemidiagnose\r\n- Nyresvikt - knyttet til nyrefunksjonstester eller en formell nyresviktdiagnose.\r\n- Står i transplantasjonskø\r\n- Pågående regelmessig behandling, som strålebehandling eller dialyse\r\n- Har fått transplantert et organ eller implantert metall i kroppen.\r\n- Pågående utredning/oppfølging av mistenkt eller verifisert malign lidelse.\r\n- Deltagelse i klinisk studie.\r\n- Står på blodfortynnende behandling.",
          "misuse" : "Skal ikke brukes for å registrere en klinisk intervensjon (f.eks. en undersøkelse eller behandling) som ikke må utføres på grunn av sannsynligheten eller muligheten for skade på individet. Bruk EVALUATION.contraindication (Norsk: Kontraindikasjon) for dette formålet.\r\n\r\nSkal ikke brukes for beslutninger om avgrensing av behandling eller fremtidige intervensjoner, eller for å registrere individets preferanser om fremtidig behandling og omsorg. Bruk henholdsvis EVALUATION.advance_intervention_decisions (Behandlingsbegrensning) og EVALUATION.advance_care_directive (Fremtidig behandlingsvalg) for dette formålet.",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "pt-br" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "pt-br"
          },
          "purpose" : "Para gravar uma condição ou estado do indivíduo que é clinicamente significante e único ou idiossincrásico para este indivíduo, e é considerada informação vital na tomada de decisão clínica.",
          "keywords" : [ "precaução", "prevenir", "evitar", "evento adverso", "prevenção", "cuidado", "alerta", "atenção" ],
          "use" : "Usado para gravar uma condição ou estado do indivíduo que é clinicamente significante e único ou idiossincrásico para este indivíduo, e é considerada informação vital na tomada de decisão clínica.\r\n\r\nEste arquétipo deve ser considerado como crítico para qualquer teste de sistema de suporte à decisão clínica para qualquer precaução terapêutica relevante como o início de uma intervenção clínica a um indivíduo por um clínico.\r\n\r\nExemplos de condições que garantem a criação de uma precaução incluem, mas não são limitadas a:\r\n- imunossuprimido/em terapia imunossupressiva - ligado à solicitação de medicação para quimioterápicos ou esteróides; ou diagnóstico de leucemia;\r\n- falência renal - ligado a testes de função renal e/ou um diagnóstico formal de falência renal;\r\n- na espera por transplante de órgãos;\r\n- em tratamento regular de radioterapia ou diálise;\r\n- transplantado ou com implante metálico in situ;\r\n- em investigação ou acompanhamento de suspeita ou confirmação de doença maligna;\r\n- participação em pesquisa farmacológica; ou\r\n- em tratamento com anticoagulante.\r\n",
          "misuse" : "*Not to be used to record a clinical intervention (including, but not limited to, use of a treatment or performance of a test or procedure) that should not be carried out due to the likelihood, or possibility, of harm being caused to an individual. Use the EVALUATION.contraindication for this purpose.\r\n\r\nNot to be used to record decisions about limitations on the individuals care or future interventions or the individuals preferences of future medical treatment and care. Use EVALUATION.advance_intervention_decisions and EVALUATION.advance_care_directive respectively for this purpose. (en)",
          "originalResourceUri" : { },
          "otherDetails" : { }
        },
        "en" : {
          "@type" : "RESOURCE_DESCRIPTION_ITEM",
          "language" : {
            "terminologyId" : {
              "value" : "ISO_639-1"
            },
            "codeString" : "en"
          },
          "purpose" : "To record a condition or state of the individual that is clinically significant and unique or idiosyncratic for this individual, and is considered vital information when making treatment decisions.",
          "keywords" : [ "precaution", "prevent", "avoid", "adverse event", "prevention", "caution", "alert", "warning" ],
          "use" : "Use to record a condition or state of the individual that is clinically significant and unique or idiosyncratic for this individual, and which are considered vital information when making treatment decisions.\r\n\r\nThis archetype should be regarded as a critical archetype by any clinical decision support system testing for any relevant therapeutic precautions as a clinician commences a new clinical intervention for an individual. \r\n\r\nExamples of conditions that warrant creation of a precaution include, but are not limited to:\r\n- Immunosuppressed/on immunosuppressive therapy – linked to medication order for chemo or steroids; or diagnosis of leukaemia;\r\n- Renal failure – linked to renal function tests and/or a formal diagnosis of renal failure;\r\n- Waiting for organ transplant;\r\n- Undergoing a regular treatment such as radiation therapy or dialysis;\r\n- Transplanted organ or metal implant in situ;\r\n- Ongoing investigation or follow up of suspected or verified malignant disease;\r\n- Participation in a pharmacological trial; or\r\n- Using anticoagulant treatment.",
          "misuse" : "Not to be used to record a clinical intervention (including, but not limited to, use of a treatment or performance of a test or procedure) that should not be carried out due to the likelihood, or possibility, of harm being caused to an individual. Use the EVALUATION.contraindication for this purpose.\r\n\r\nNot to be used to record decisions about limitations on the individuals care or future interventions or the individuals preferences of future medical treatment and care. Use EVALUATION.advance_intervention_decisions and EVALUATION.advance_care_directive respectively for this purpose.",
          "copyright" : "© openEHR Foundation",
          "originalResourceUri" : { },
          "otherDetails" : { }
        }
      }
    },
    "parentArchetypeId" : "openEHR-EHR-EVALUATION.precaution.v1",
    "differential" : false,
    "archetypeId" : {
      "@type" : "ARCHETYPE_HRID",
      "value" : "openEHR-EHR-EVALUATION.ovl-precaution-001.v1"
    },
    "definition" : {
      "@type" : "C_COMPLEX_OBJECT",
      "rmTypeName" : "EVALUATION",
      "occurrences" : "1..1",
      "nodeId" : "at0000.1",
      "attributes" : [ {
        "@type" : "C_ATTRIBUTE",
        "rmAttributeName" : "data",
        "existence" : "1..1",
        "children" : [ {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ITEM_TREE",
          "occurrences" : "1..1",
          "nodeId" : "at0001",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "items",
            "existence" : "0..1",
            "cardinality" : {
              "@type" : "CARDINALITY",
              "interval" : "1..*",
              "ordered" : false,
              "unique" : false
            },
            "children" : [ {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "1..1",
              "nodeId" : "at0002.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0014.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_CODED_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ {
                    "@type" : "C_ATTRIBUTE",
                    "rmAttributeName" : "defining_code",
                    "existence" : "1..1",
                    "children" : [ {
                      "@type" : "C_TERMINOLOGY_CODE",
                      "rmTypeName" : "TERMINOLOGY_CODE",
                      "occurrences" : "1..1",
                      "terminologyId" : {
                        "value" : "local"
                      },
                      "constraint" : [ "ac0.1" ],
                      "selectedTerminologies" : [ ]
                    } ]
                  } ],
                  "attributeTuples" : [ ]
                }, {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0003.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0013.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "ARCHETYPE_SLOT",
              "rmTypeName" : "CLUSTER",
              "occurrences" : "0..*",
              "nodeId" : "at0025",
              "includes" : [ {
                "@type" : "ASSERTION",
                "stringExpression" : "archetype_id/value matches {/openEHR-EHR-CLUSTER\\.clinical_evidence\\.v1/}",
                "expression" : {
                  "@type" : "BINARY_OPERATOR",
                  "type" : "BOOLEAN",
                  "operator" : "matches",
                  "leftOperand" : {
                    "@type" : "MODEL_REFERENCE",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Attribute",
                    "path" : "archetype_id/value"
                  },
                  "rightOperand" : {
                    "@type" : "CONSTRAINT",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Constraint",
                    "item" : {
                      "@type" : "C_STRING",
                      "constraint" : [ "/openEHR-EHR-CLUSTER\\.clinical_evidence\\.v1/" ]
                    }
                  },
                  "precedenceOverriden" : false
                },
                "variables" : [ ]
              } ],
              "excludes" : [ ],
              "closed" : false
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0008.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_TEXT",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            } ]
          } ],
          "attributeTuples" : [ ]
        } ]
      }, {
        "@type" : "C_ATTRIBUTE",
        "rmAttributeName" : "protocol",
        "existence" : "0..1",
        "children" : [ {
          "@type" : "C_COMPLEX_OBJECT",
          "rmTypeName" : "ITEM_TREE",
          "occurrences" : "1..1",
          "nodeId" : "at0006",
          "attributes" : [ {
            "@type" : "C_ATTRIBUTE",
            "rmAttributeName" : "items",
            "existence" : "0..1",
            "cardinality" : {
              "@type" : "CARDINALITY",
              "interval" : "0..*",
              "ordered" : false,
              "unique" : false
            },
            "children" : [ {
              "@type" : "ARCHETYPE_SLOT",
              "rmTypeName" : "CLUSTER",
              "occurrences" : "0..*",
              "nodeId" : "at0020",
              "includes" : [ {
                "@type" : "ASSERTION",
                "stringExpression" : "archetype_id/value matches {/.*/}",
                "expression" : {
                  "@type" : "BINARY_OPERATOR",
                  "type" : "BOOLEAN",
                  "operator" : "matches",
                  "leftOperand" : {
                    "@type" : "MODEL_REFERENCE",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Attribute",
                    "path" : "archetype_id/value"
                  },
                  "rightOperand" : {
                    "@type" : "CONSTRAINT",
                    "type" : "STRING",
                    "precedenceOverriden" : false,
                    "referenceType" : "Constraint",
                    "item" : {
                      "@type" : "C_STRING",
                      "constraint" : [ "/.*/" ]
                    }
                  },
                  "precedenceOverriden" : false
                },
                "variables" : [ ]
              } ],
              "excludes" : [ ],
              "closed" : false
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0022.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0024.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0009.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            }, {
              "@type" : "C_COMPLEX_OBJECT",
              "rmTypeName" : "ELEMENT",
              "occurrences" : "0..0",
              "nodeId" : "at0004.1",
              "attributes" : [ {
                "@type" : "C_ATTRIBUTE",
                "rmAttributeName" : "value",
                "existence" : "0..1",
                "children" : [ {
                  "@type" : "C_COMPLEX_OBJECT",
                  "rmTypeName" : "DV_DATE_TIME",
                  "occurrences" : "1..1",
                  "attributes" : [ ],
                  "attributeTuples" : [ ]
                } ]
              } ],
              "attributeTuples" : [ ]
            } ]
          } ],
          "attributeTuples" : [ ]
        } ]
      } ],
      "attributeTuples" : [ ]
    },
    "terminology" : {
      "@type" : "ARCHETYPE_TERMINOLOGY",
      "conceptCode" : "at0000",
      "termDefinitions" : {
        "en" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "(Synthesized)",
            "code" : "ac0.1",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Precaution",
            "description" : "A condition or state of the individual that is clinically significant and unique or idiosyncratic for this individual, and is considered vital information when making treatment decisions."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Condition",
            "description" : "Identification, by name, of a condition or state.",
            "comment" : "Coding of the identified 'Condition' with a terminology is desirable, where possible."
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Evidence",
            "description" : "Description of the evidence identified to support the precaution.",
            "comment" : "This data element can be optionally linked to a diagnosis, test result, medication order etc via a URI (as per the Reference Model) in order to provide the rationale or evidence for the precaution assertion. Please note: as this URI link may not be accessible from a message or by receiving clinical system it is desirable that a narrative description of the evidence should also be explicitly recorded."
          },
          "at0004" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Last updated",
            "description" : "Date when the precaution information was last updated."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0008" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Comment",
            "description" : "Additional narrative about the precaution, not captured in other fields."
          },
          "at0009" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Review date",
            "description" : "Date when next due for review by a clinician.",
            "comment" : "In circumstances where precautions are not indefinite or life-long, use this data element to record the date/time when this precaution should be reassessed in the context of the clinical circumstances at the time."
          },
          "at0013" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Category",
            "description" : "Type of the 'Condition' identified.",
            "comment" : "This data element has been included because it is currently being captured in some clinical systems. This information could be derived when terminology codes are used to represent the condition in clinical systems, and is effectively redundant in that situation."
          },
          "at0014" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Status",
            "description" : "Assertion about the current state of the identified 'Precaution'.",
            "comment" : "Decision support would typically raise alerts for 'Active' and ignore a 'Resolved' or 'Refuted' precaution. Clinical systems may choose not to display Precaution entries with a 'Refuted' status in the Precaution list. However, 'Refuted' may be useful for reconciliation of the Precaution list or when communicating between systems. Some implementations may choose to make this field mandatory. 'Resolved' may be used variably across systems, depending on clinical use and context. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology."
          },
          "at0015" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0015",
            "text" : "Active",
            "description" : "The precaution is currently active."
          },
          "at0018" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0018",
            "text" : "Resolved",
            "description" : "The previously asserted precaution has been clinically reassessed and considered no longer to be an active risk."
          },
          "at0019" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0019",
            "text" : "Refuted",
            "description" : "The precaution has been clinically reassessed or has been disproved with a high level of clinical certainty by testing."
          },
          "at0020" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0020",
            "text" : "Extension",
            "description" : "Additional information required to capture local content or to align with other reference models/formalisms.",
            "comment" : "For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents."
          },
          "at0022" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Valid period start",
            "description" : "Date/time after which the 'Condition' is regarded as active.",
            "comment" : "This data element is intended for use when a precaution is identified to start at some time in the future. For example: the commencement date for a pharmaceutical trial."
          },
          "at0024" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Valid period end",
            "description" : "Date/time after which the 'Condition' is regarded as inactive.",
            "comment" : "This data element is intended for use when a precaution is known to have a definitive end date/time in the future. For example: the cessation date for a pharmaceutical trial."
          },
          "at0025" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0025",
            "text" : "Additional details",
            "description" : "Additional structured details about the precaution.",
            "comment" : "For example: clinical evidence supporting the precaution."
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Condition",
            "description" : "Identification, by name, of a condition or state.",
            "comment" : "Coding of the identified 'Condition' with a terminology is desirable, where possible."
          },
          "at0013.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Category",
            "description" : "Type of the 'Condition' identified.",
            "comment" : "This data element has been included because it is currently being captured in some clinical systems. This information could be derived when terminology codes are used to represent the condition in clinical systems, and is effectively redundant in that situation."
          },
          "at0014.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Status",
            "description" : "Assertion about the current state of the identified 'Precaution'.",
            "comment" : "Decision support would typically raise alerts for 'Active' and ignore a 'Resolved' or 'Refuted' precaution. Clinical systems may choose not to display Precaution entries with a 'Refuted' status in the Precaution list. However, 'Refuted' may be useful for reconciliation of the Precaution list or when communicating between systems. Some implementations may choose to make this field mandatory. 'Resolved' may be used variably across systems, depending on clinical use and context. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology."
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Evidence",
            "description" : "Description of the evidence identified to support the precaution.",
            "comment" : "This data element can be optionally linked to a diagnosis, test result, medication order etc via a URI (as per the Reference Model) in order to provide the rationale or evidence for the precaution assertion. Please note: as this URI link may not be accessible from a message or by receiving clinical system it is desirable that a narrative description of the evidence should also be explicitly recorded."
          },
          "at0024.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Valid period end",
            "description" : "Date/time after which the 'Condition' is regarded as inactive.",
            "comment" : "This data element is intended for use when a precaution is known to have a definitive end date/time in the future. For example: the cessation date for a pharmaceutical trial."
          },
          "at0004.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Last updated",
            "description" : "Date when the precaution information was last updated."
          },
          "at0008.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Comment",
            "description" : "Additional narrative about the precaution, not captured in other fields."
          },
          "at0009.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Review date",
            "description" : "Date when next due for review by a clinician.",
            "comment" : "In circumstances where precautions are not indefinite or life-long, use this data element to record the date/time when this precaution should be reassessed in the context of the clinical circumstances at the time."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Precaution",
            "description" : "A condition or state of the individual that is clinically significant and unique or idiosyncratic for this individual, and is considered vital information when making treatment decisions."
          },
          "at0022.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Valid period start",
            "description" : "Date/time after which the 'Condition' is regarded as active.",
            "comment" : "This data element is intended for use when a precaution is identified to start at some time in the future. For example: the commencement date for a pharmaceutical trial."
          }
        },
        "nb" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Forholdsregel",
            "description" : "En klinisk tilstand eller status som er unik eller særegen for et individ, og som regnes som viktig informasjon i forbindelse med beslutninger om behandling."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Tilstand",
            "description" : "Navnet på tilstanden eller statusen.",
            "comment" : "Koding av tilstanden med en terminologi er ønskelig, dersom mulig."
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Underlag",
            "description" : "Beskrivelse av underlaget som understøtter forholdsregelen.",
            "comment" : "Dette dataelementet kan dersom ønskelig lenkes til en diagnose, testresultat eller legemiddelordinering ved hjelp av en URI (spesifisert i referansemodellen) for å oppgi rasjonalet eller evidensen for forholdsregelen. NB: Siden URI-lenken kan være utilgjengelige fra en melding eller et mottakende system, er det ønskelig at en fritekstbeskrivelse av underlaget registreres eksplisitt."
          },
          "at0004" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Sist oppdatert",
            "description" : "Dato da forholdsregelinformasjonen sist ble oppdatert."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0008" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Kommentar",
            "description" : "Ytterligere informasjon om forholdsregelen, som ikke kan registreres i andre felter."
          },
          "at0009" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Evalueringsdato",
            "description" : "Dato for neste kliniske evaluering.",
            "comment" : "Ved omstendigheter der forholdsregler ikke er på ubestemt tid eller livslange, kan dette dataelementet brukes til å registrere når forholdsregelen bør evalueres."
          },
          "at0013" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Kategori",
            "description" : "Type \"Tilstand\".",
            "comment" : "Dette dataelementet er inkludert fordi det registreres i flere eksisterende kliniske systemer. Informasjonen kan avledes fra Tilstand dersom hierarkiske kodesystemer er brukt, og vil i slike tilfeller være redundant."
          },
          "at0014" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Status",
            "description" : "Forholdsregelens nåværende status.",
            "comment" : "Beslutningsstøtte vil typisk utløse advarsler for \"Aktiv\", og ignorere \"Opphørt\" eller \"Avkreftet\". Kliniske systemer kan velge å ikke vise registreringer med status \"Avkreftet\" i en liste. Likevel kan \"Avkreftet\" være nyttig for sammenstilling av ulike lister eller ved kommunikasjon mellom systemer. Noen systemer kan velge å gjøre dette elementet obligatorisk. \"Opphørt\" kan brukes ulikt i ulike systemer avhengig av klinisk bruk og kontekst. Fritekst-datatypen tillater lokal variasjon ved å gjøre det mulig å bruke andre verdisett for dette dataelementet i en templat. Det er i denne situasjonen anbefalt å kode verdiene med en terminologi."
          },
          "at0015" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0015",
            "text" : "Aktiv",
            "description" : "Forholdsregelen er aktiv."
          },
          "at0018" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0018",
            "text" : "Opphørt",
            "description" : "Den tidligere kjente forholdsregelen er klinisk revurdert ved testing, og regnes ikke lenger for å være en aktiv risiko."
          },
          "at0019" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0019",
            "text" : "Avkreftet",
            "description" : "Forholdsregelen har blitt klinisk revurdert eller er avkreftet med høy grad av sikkerhet ved testing."
          },
          "at0020" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0020",
            "text" : "Tilleggsinformasjon",
            "description" : "Ytterligere informasjon som trengs for å kunne registrere lokalt definert innhold eller for å tilpasse til andre referansemodeller/formalismer.",
            "comment" : "For eksempel lokale informasjonsbehov eller ytterligere metadata for å kunne tilpasse til tilsvarende konsepter i FHIR eller CIMI."
          },
          "at0022" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Gyldighetsperiode start",
            "description" : "Forholdsregelen regnes som aktiv etter denne datoen.",
            "comment" : "Dette dataelementet er ment for å brukes når en forholdregel er ment å starte på et tidspunkt i fremtiden, for eksempel startdatoen for en farmakologisk studie."
          },
          "at0024" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Gyldighetsperiode slutt",
            "description" : "Forholdsregelen regnes som inaktiv etter denne datoen.",
            "comment" : "Dette dataelementet er ment for å brukes når en forholdsregel er ment å avsluttes på et tidspunkt i fremtiden, for eksempel sluttdatoen for en farmakologisk studie."
          },
          "at0025" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0025",
            "text" : "Ytterligere detaljer",
            "description" : "Ytterligere strukturerte detaljer om forholdsregelen.",
            "comment" : "For eksempel: det kliniske grunnlaget for forholdsregelen."
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Tilstand",
            "description" : "Navnet på tilstanden eller statusen.",
            "comment" : "Koding av tilstanden med en terminologi er ønskelig, dersom mulig."
          },
          "at0013.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Kategori",
            "description" : "Type \"Tilstand\".",
            "comment" : "Dette dataelementet er inkludert fordi det registreres i flere eksisterende kliniske systemer. Informasjonen kan avledes fra Tilstand dersom hierarkiske kodesystemer er brukt, og vil i slike tilfeller være redundant."
          },
          "at0014.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Status",
            "description" : "Forholdsregelens nåværende status.",
            "comment" : "Beslutningsstøtte vil typisk utløse advarsler for \"Aktiv\", og ignorere \"Opphørt\" eller \"Avkreftet\". Kliniske systemer kan velge å ikke vise registreringer med status \"Avkreftet\" i en liste. Likevel kan \"Avkreftet\" være nyttig for sammenstilling av ulike lister eller ved kommunikasjon mellom systemer. Noen systemer kan velge å gjøre dette elementet obligatorisk. \"Opphørt\" kan brukes ulikt i ulike systemer avhengig av klinisk bruk og kontekst. Fritekst-datatypen tillater lokal variasjon ved å gjøre det mulig å bruke andre verdisett for dette dataelementet i en templat. Det er i denne situasjonen anbefalt å kode verdiene med en terminologi."
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Underlag",
            "description" : "Beskrivelse av underlaget som understøtter forholdsregelen.",
            "comment" : "Dette dataelementet kan dersom ønskelig lenkes til en diagnose, testresultat eller legemiddelordinering ved hjelp av en URI (spesifisert i referansemodellen) for å oppgi rasjonalet eller evidensen for forholdsregelen. NB: Siden URI-lenken kan være utilgjengelige fra en melding eller et mottakende system, er det ønskelig at en fritekstbeskrivelse av underlaget registreres eksplisitt."
          },
          "at0024.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Gyldighetsperiode slutt",
            "description" : "Forholdsregelen regnes som inaktiv etter denne datoen.",
            "comment" : "Dette dataelementet er ment for å brukes når en forholdsregel er ment å avsluttes på et tidspunkt i fremtiden, for eksempel sluttdatoen for en farmakologisk studie."
          },
          "at0004.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Sist oppdatert",
            "description" : "Dato da forholdsregelinformasjonen sist ble oppdatert."
          },
          "at0008.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Kommentar",
            "description" : "Ytterligere informasjon om forholdsregelen, som ikke kan registreres i andre felter."
          },
          "at0009.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Evalueringsdato",
            "description" : "Dato for neste kliniske evaluering.",
            "comment" : "Ved omstendigheter der forholdsregler ikke er på ubestemt tid eller livslange, kan dette dataelementet brukes til å registrere når forholdsregelen bør evalueres."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Forholdsregel",
            "description" : "En klinisk tilstand eller status som er unik eller særegen for et individ, og som regnes som viktig informasjon i forbindelse med beslutninger om behandling."
          },
          "at0022.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Gyldighetsperiode start",
            "description" : "Forholdsregelen regnes som aktiv etter denne datoen.",
            "comment" : "Dette dataelementet er ment for å brukes når en forholdregel er ment å starte på et tidspunkt i fremtiden, for eksempel startdatoen for en farmakologisk studie."
          }
        },
        "es-ar" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Precaución",
            "description" : "Una afección o estado del individuo que es clínicamente significativa y única o idiosincrática para con este individuo, y que se considera información vital al momento de la toma de decisiones."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Condición",
            "description" : "Identificación, por nombre, de la condición o estado.",
            "comment" : "La codificación de la 'condición' identificada mediante una terminología es deseable cuando sea posible."
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Evidencia",
            "description" : "Descripción de la evidencia identificada que fundamenta la precaución.",
            "comment" : "Este elemento puede ser opcionalmente vinculado a un diagnóstico, resultado de prueba, orden de medicamento, etc., a través de una URI (conforme al Modelo de Referencia) a fin de proveer la base o evidencia para la precaución declarada. Se debe tener en cuenta que dado que este vínculo URI puede no ser accesible desde un mensaje o por el sistema clínico receptor, resulta deseable que se registre explícitamente una descripción narrativa de la evidencia."
          },
          "at0004" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Última actualización",
            "description" : "Fecha en la cual la información sobre la precaución fue actualizada por última vez."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0008" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Comentario",
            "description" : "Narrativa adicional acerca de la precaución, no registrada en otros campos."
          },
          "at0009" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Fecha de Revisión",
            "description" : "La fecha en la cual un clínico debe efectuar una revisión.",
            "comment" : "En circunstancias en las cuales las precauciones no son indefinidas o de por vida, se debe utilizar este elemento para registrar la fecha y hora en la cual esta precaución debe ser reevaluada en el contexto de las circunstancias clínicas imperantes en el momento."
          },
          "at0013" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Categoría",
            "description" : "Tipo de 'condición' identificada.",
            "comment" : "Este elemento ha sido incluido dado que esta siendo actualmente registrado en algunos sistemas clínicos. Esta información podrá ser derivada cuando se utilicen códigos terminológicos para representar la condición en sistemas clínicos y es efectivamente redundante en tales situaciones."
          },
          "at0014" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Estado",
            "description" : "Aserción acerca del estado actual de la 'Precaución' identificada.",
            "comment" : "El apoyo a la decisión típicamente producirá alertas para una precaución 'Activa' e ignorará las del tipo 'Resuelta' o 'Refutada'. Los sistemas clínicos podrían optar por no exhibir asientos con un estado 'Refutada' en la lista de Precauciones. No obstante, 'Refutada' puede resultar útil para la conciliación de la lista de Precauciones o en la comunicación entre sistemas. Algunas implementaciones podrían resolver hacer obligatorio este campo. 'Resuelta' puede ser utilizada en forma diversa dependiendo del uso clínico o del contexto. El tipo de dato de texto libre habilita a la adaptación a usos locales al permitir otros conjuntos de datos para este elemento en una plantilla. En tales casos se recomienda que los valores sean codificados mediante una terminología."
          },
          "at0015" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0015",
            "text" : "Activa",
            "description" : "La precaución se encuentra actualmente activa."
          },
          "at0018" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0018",
            "text" : "Resuelta",
            "description" : "La precaución previamente declarada ha sido reevaluada clínicamente y ya no es considerada como un riesgo activo."
          },
          "at0019" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0019",
            "text" : "Refutada",
            "description" : "La precaución previamente declarada ha sido reevaluada clínicamente o negada con un grado alto de certeza a través de pruebas."
          },
          "at0020" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0020",
            "text" : "Extensión",
            "description" : "Información adicional requerida para registrar contenido local o para el alineamiento con otros modelos de referencia o formalismos.",
            "comment" : "Por ejemplo: requerimientos locales de información o metadatos adicionales para el alineamiento con equivalentes FHIR o CIMI."
          },
          "at0022" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Comienzo del período de validez",
            "description" : "Fecha y hora a partir de la cual la 'condición' debe considerarse activa.",
            "comment" : "Este elemento se utiliza cuando se pretende que una precaución tenga vigencia en algún momento futuro. Por ejemplo: la fecha de comienzo de un ensayo farmacológico."
          },
          "at0024" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Final del período de validez",
            "description" : "Fecha y hora a partir de la cual la 'condición' debe considerarse inactiva.",
            "comment" : "Este elemento se utiliza cuando una precaución tiene una fecha de finalización futura conocida. Por ejemplo: la fecha de finalización de un ensayo farmacológico."
          },
          "at0025" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0025",
            "text" : "*Additional details (en)",
            "description" : "*Additional structured details about the precaution. (en)",
            "comment" : "*For example: clinical evidence supporting the precaution. (en)"
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Condición",
            "description" : "Identificación, por nombre, de la condición o estado.",
            "comment" : "La codificación de la 'condición' identificada mediante una terminología es deseable cuando sea posible."
          },
          "at0013.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Categoría",
            "description" : "Tipo de 'condición' identificada.",
            "comment" : "Este elemento ha sido incluido dado que esta siendo actualmente registrado en algunos sistemas clínicos. Esta información podrá ser derivada cuando se utilicen códigos terminológicos para representar la condición en sistemas clínicos y es efectivamente redundante en tales situaciones."
          },
          "at0014.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Estado",
            "description" : "Aserción acerca del estado actual de la 'Precaución' identificada.",
            "comment" : "El apoyo a la decisión típicamente producirá alertas para una precaución 'Activa' e ignorará las del tipo 'Resuelta' o 'Refutada'. Los sistemas clínicos podrían optar por no exhibir asientos con un estado 'Refutada' en la lista de Precauciones. No obstante, 'Refutada' puede resultar útil para la conciliación de la lista de Precauciones o en la comunicación entre sistemas. Algunas implementaciones podrían resolver hacer obligatorio este campo. 'Resuelta' puede ser utilizada en forma diversa dependiendo del uso clínico o del contexto. El tipo de dato de texto libre habilita a la adaptación a usos locales al permitir otros conjuntos de datos para este elemento en una plantilla. En tales casos se recomienda que los valores sean codificados mediante una terminología."
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Evidencia",
            "description" : "Descripción de la evidencia identificada que fundamenta la precaución.",
            "comment" : "Este elemento puede ser opcionalmente vinculado a un diagnóstico, resultado de prueba, orden de medicamento, etc., a través de una URI (conforme al Modelo de Referencia) a fin de proveer la base o evidencia para la precaución declarada. Se debe tener en cuenta que dado que este vínculo URI puede no ser accesible desde un mensaje o por el sistema clínico receptor, resulta deseable que se registre explícitamente una descripción narrativa de la evidencia."
          },
          "at0024.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Final del período de validez",
            "description" : "Fecha y hora a partir de la cual la 'condición' debe considerarse inactiva.",
            "comment" : "Este elemento se utiliza cuando una precaución tiene una fecha de finalización futura conocida. Por ejemplo: la fecha de finalización de un ensayo farmacológico."
          },
          "at0004.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Última actualización",
            "description" : "Fecha en la cual la información sobre la precaución fue actualizada por última vez."
          },
          "at0008.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Comentario",
            "description" : "Narrativa adicional acerca de la precaución, no registrada en otros campos."
          },
          "at0009.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Fecha de Revisión",
            "description" : "La fecha en la cual un clínico debe efectuar una revisión.",
            "comment" : "En circunstancias en las cuales las precauciones no son indefinidas o de por vida, se debe utilizar este elemento para registrar la fecha y hora en la cual esta precaución debe ser reevaluada en el contexto de las circunstancias clínicas imperantes en el momento."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Precaución",
            "description" : "Una afección o estado del individuo que es clínicamente significativa y única o idiosincrática para con este individuo, y que se considera información vital al momento de la toma de decisiones."
          },
          "at0022.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Comienzo del período de validez",
            "description" : "Fecha y hora a partir de la cual la 'condición' debe considerarse activa.",
            "comment" : "Este elemento se utiliza cuando se pretende que una precaución tenga vigencia en algún momento futuro. Por ejemplo: la fecha de comienzo de un ensayo farmacológico."
          }
        },
        "pt-br" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Precaução",
            "description" : "Uma condição ou estado do indivíduo que é clinicamente significante e único ou idiossincrásico para este indivíduo, e é considerada informação vital na tomada de decisão clínica."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Condição",
            "description" : "Identificação da condição ou estado pelo nome.",
            "comment" : "A codificação da \"Condição\" identificada com uma terminologia é desejável, quando possível."
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Evidência",
            "description" : "Descrição da evidência identificada para suportar a precaução.",
            "comment" : "Este elemento de dado pode ser opcionalmente ligado a um diagnóstico, resultado de exame, solicitação de medicamento etc via URI (como pelo Modelo de Referência) para prover uma razão ou evidência para a assertiva de precaução. Por favor note: como este link URI pode não ser acessível por uma mensagem ou pelo sistema clínico receptor é desejável que a descrição narrativa da evidência seja também explicitamente gravada."
          },
          "at0004" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Última atualização",
            "description" : "Data na qual a informação de precaução foi atualizada pela última vez."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0008" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Comentário",
            "description" : "Narrativa adicional sobre a precaução, não capturada em outros campos."
          },
          "at0009" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Data de revisão",
            "description" : "Data na qual a revisão pelo clínico deverá ser realizada.",
            "comment" : "Em circunstâncias onde as precauções não são de longo prazo ou vitalícias, use este elemento de dado para gravar a data/hora na qual esta precaução deve ser reavaliada no contexto das circunstâncias clínicas do momento."
          },
          "at0013" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Categoria",
            "description" : "Tipo de \"Condição\" identificada.",
            "comment" : "Este elemento de dado foi incluído porque é atualmente capturado em alguns sistemas clínicos. Esta informação pode ser derivada quando códigos terminológicos são utilizados para representar a condição em sistemas clínicos, e é efetivamente redundante nesta situação."
          },
          "at0014" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Estado",
            "description" : "Assertiva sobre o estado atual da \"Precaução\" identificada.",
            "comment" : "A decisão de suporte tipicamente iria levantar alertas para \"Ativa\" e ignorar uma precaução \"Resolvida\" ou \"Refutada\". Sistemas clínicos podem escolher não mostrar entradas com estado de \"refutada\" na lista de precauções. Entretanto, \"Refutada\" pode ser útil para a reconciliação da lista de precaução ou na comunicação entre sistemas. Algumas implementações podem escolher em classificar este campo como obrigatório. \"Resolvida\" pode ser usada de forma variável entre sistemas, dependendo do uso e contexto clínico. O tipo de dado texto livre irá permitir variabilidade local por possibilitar outros conjuntos de valores a serem aplicados a este elemento de dado em um modelo - neste situação é recomendado que estes valores sejam codificados utilizando uma terminologia."
          },
          "at0015" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0015",
            "text" : "Ativa",
            "description" : "A precaução é atualmente ativa."
          },
          "at0018" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0018",
            "text" : "Resolvida",
            "description" : "A precaução previamente observada foi reavaliada clinicamente e não foi considerada como um risco ativo atualmente."
          },
          "at0019" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0019",
            "text" : "Refutada",
            "description" : "A precaução foi reavaliada clinicamente ou foi reprovada com um alto grau de certeza clínica por meio de testes."
          },
          "at0020" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0020",
            "text" : "Extensão",
            "description" : "Informação adicional requerida para capturar conteúdo local ou alinhar a outros modelos de referência/formalismos.",
            "comment" : "Por exemplo: requisitos de informação local ou metadados adicionais para alinhar a equivalentes de FHIR ou CIMI."
          },
          "at0022" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Início do período válido",
            "description" : "Data/hora na qual a \"Condição\" foi considerada ativa.",
            "comment" : "Este elemento de dado é indicado para uso quando é identificado o início da precaução em algum momento no futuro. Por exemplo: a data de início para uma pesquisa farmacêutica."
          },
          "at0024" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Final do período válido",
            "description" : "Data/hora na qual a \"Condição\" foi considerada inativa.",
            "comment" : "Este elemento de dado é indicado para uso quando sabe-se que a precaução tem uma data de finalização no futuro. Por exemplo: a data de término de uma pesquisa clínica."
          },
          "at0025" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0025",
            "text" : "*Additional details (en)",
            "description" : "*Additional structured details about the precaution. (en)",
            "comment" : "*For example: clinical evidence supporting the precaution. (en)"
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Condição",
            "description" : "Identificação da condição ou estado pelo nome.",
            "comment" : "A codificação da \"Condição\" identificada com uma terminologia é desejável, quando possível."
          },
          "at0013.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Categoria",
            "description" : "Tipo de \"Condição\" identificada.",
            "comment" : "Este elemento de dado foi incluído porque é atualmente capturado em alguns sistemas clínicos. Esta informação pode ser derivada quando códigos terminológicos são utilizados para representar a condição em sistemas clínicos, e é efetivamente redundante nesta situação."
          },
          "at0014.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Estado",
            "description" : "Assertiva sobre o estado atual da \"Precaução\" identificada.",
            "comment" : "A decisão de suporte tipicamente iria levantar alertas para \"Ativa\" e ignorar uma precaução \"Resolvida\" ou \"Refutada\". Sistemas clínicos podem escolher não mostrar entradas com estado de \"refutada\" na lista de precauções. Entretanto, \"Refutada\" pode ser útil para a reconciliação da lista de precaução ou na comunicação entre sistemas. Algumas implementações podem escolher em classificar este campo como obrigatório. \"Resolvida\" pode ser usada de forma variável entre sistemas, dependendo do uso e contexto clínico. O tipo de dado texto livre irá permitir variabilidade local por possibilitar outros conjuntos de valores a serem aplicados a este elemento de dado em um modelo - neste situação é recomendado que estes valores sejam codificados utilizando uma terminologia."
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Evidência",
            "description" : "Descrição da evidência identificada para suportar a precaução.",
            "comment" : "Este elemento de dado pode ser opcionalmente ligado a um diagnóstico, resultado de exame, solicitação de medicamento etc via URI (como pelo Modelo de Referência) para prover uma razão ou evidência para a assertiva de precaução. Por favor note: como este link URI pode não ser acessível por uma mensagem ou pelo sistema clínico receptor é desejável que a descrição narrativa da evidência seja também explicitamente gravada."
          },
          "at0024.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Final do período válido",
            "description" : "Data/hora na qual a \"Condição\" foi considerada inativa.",
            "comment" : "Este elemento de dado é indicado para uso quando sabe-se que a precaução tem uma data de finalização no futuro. Por exemplo: a data de término de uma pesquisa clínica."
          },
          "at0004.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Última atualização",
            "description" : "Data na qual a informação de precaução foi atualizada pela última vez."
          },
          "at0008.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Comentário",
            "description" : "Narrativa adicional sobre a precaução, não capturada em outros campos."
          },
          "at0009.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Data de revisão",
            "description" : "Data na qual a revisão pelo clínico deverá ser realizada.",
            "comment" : "Em circunstâncias onde as precauções não são de longo prazo ou vitalícias, use este elemento de dado para gravar a data/hora na qual esta precaução deve ser reavaliada no contexto das circunstâncias clínicas do momento."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Precaução",
            "description" : "Uma condição ou estado do indivíduo que é clinicamente significante e único ou idiossincrásico para este indivíduo, e é considerada informação vital na tomada de decisão clínica."
          },
          "at0022.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Início do período válido",
            "description" : "Data/hora na qual a \"Condição\" foi considerada ativa.",
            "comment" : "Este elemento de dado é indicado para uso quando é identificado o início da precaução em algum momento no futuro. Por exemplo: a data de início para uma pesquisa farmacêutica."
          }
        },
        "sv" : {
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Försiktighetsåtgärd",
            "description" : "Ett tillstånd eller status hos en individ som är kliniskt signifikant och unik eller idiosynkratisk för den här individen och anses vara vital information i samband med beslut om behandling."
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Tillstånd",
            "description" : "Namnet på tillståndet eller statusen.",
            "comment" : "Kodning med en terminologi till det identifierade tillståndet är önskvärt där så är möjligt."
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Belägg",
            "description" : "Beskrivning av de belägg som identifierats vilka stödjer försiktighetsåtgärden.",
            "comment" : "Det här data elementet kan valfritt länkas till en diagnos, testresultat, läkemedelsordination etc via ett URI (enligt Referensmodellen) i syfte att förse den logiska grunden eller bevisen för den påstådda försiktighetsåtgärden. Vänligen notera: eftersom den här URI-länken kanske inte är tillgänglig från ett meddelande eller att kliniska system inte kan ta emot den är det önskvärt att en berättande beskrivning görs av fynden samt att de blir tydligt dokumenterade."
          },
          "at0004" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Senast uppdaterad",
            "description" : "Datum då informationen om försiktighetsåtgärden senast uppdaterades."
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0008" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Kommentar",
            "description" : "Ytterligare beskrivning av försiktighetsåtgärden som inte fångas i några andra fält."
          },
          "at0009" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Granskningsdatum",
            "description" : "Lämpligt datum för nästa granskning av en kliniker.",
            "comment" : "Vid omständigheter där försiktighetsåtgärden inte är definitiv eller livslång, använd då det här dataelementet för att dokumentera datum eller tid när försiktighetsåtgärden bör omvärderas i förhållande till den kliniska kontexten för det aktuella tillfället."
          },
          "at0013" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Kategori",
            "description" : "Typ av identifierat tillstånd.",
            "comment" : "Det här dataelementet har inkluderats eftersom det för närvarande fångas i en del kliniska system. Informationen kan härledas när terminologikoder används för att representera tillståndet i ett kliniskt system och är effektivt redundant i en sådan situation."
          },
          "at0014" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Status",
            "description" : "Försiktighetsåtgärdens nuvarande status.",
            "comment" : "Beslutsstöd bör meddela varningar för 'Aktiv' och ignorera 'Upphört' eller 'Avfärdad'. Kliniska system kan välja att inte visa anteckningar om försiktighetsåtgärder med statusen 'Avfärdad' i en lista med försiktighetsåtgärder. Emellertid kan 'Avfärdad' vara användbar vid sammanställning av listor med försiktighetsåtgärder eller vid kommunikation mellan system. Några system kan välja att göra detta element till obligatoriskt. 'Upphört' kan användas olika över olika system beroende på klinisk användning och kontext. Fritextdatatypen tillåter lokal variation, vilket gör att andra värdesatser kan användas i det här dataelementet i en template. Vid sådana situationer rekommenderas att värden kodas med hjälp av en terminologi."
          },
          "at0015" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0015",
            "text" : "Aktiv",
            "description" : "Försiktighetsåtgärden är för närvarande aktiv."
          },
          "at0018" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0018",
            "text" : "Upphört",
            "description" : "Den tidigare kända försiktighetsåtgärden har blivit kliniskt omvärderad och anses inte längre vara en aktiv risk."
          },
          "at0019" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0019",
            "text" : "Avfärdad",
            "description" : "Försiktighetsåtgärden har blivit kliniskt omvärderad eller genom tester blivit motbevisad med en hög grad av klinisk säkerhet"
          },
          "at0020" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0020",
            "text" : "Tilläggsinformation",
            "description" : "Plats för att infoga tilläggsinformation som krävs för lokala anpassningar eller anpassning till andra referensmodeller eller formella krav.",
            "comment" : "Exempelvis lokala informationskrav eller metadata för anpassning till FHIR- eller CIMI-motsvarigheter."
          },
          "at0022" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Giltlig startperiod",
            "description" : "Datum eller tid från vilket tillståndet anses vara aktivt.",
            "comment" : "Det här dataelementet syftar till att användas när en försiktighetsåtgärd beräknas starta någon gång i framtiden. Exempelvis det inledande datumet för en läkemedelsprövning."
          },
          "at0024" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Giltlig slutperiod",
            "description" : "Datum eller tid från vilket tillståndet anses vara inaktivt.",
            "comment" : "Det här dataelementet syftar till att användas när en försiktighetsåtgärd har ett definitivt slutdatum eller tid någon gång i framtiden. Exempelvis det datum då en läkemedelsprövning upphör."
          },
          "at0025" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0025",
            "text" : "*Additional details(en)",
            "description" : "*Additional structured details about the precaution.(en)",
            "comment" : "*For example: clinical evidence supporting the precaution.(en)"
          },
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "Tillstånd",
            "description" : "Namnet på tillståndet eller statusen.",
            "comment" : "Kodning med en terminologi till det identifierade tillståndet är önskvärt där så är möjligt."
          },
          "at0013.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "Kategori",
            "description" : "Typ av identifierat tillstånd.",
            "comment" : "Det här dataelementet har inkluderats eftersom det för närvarande fångas i en del kliniska system. Informationen kan härledas när terminologikoder används för att representera tillståndet i ett kliniskt system och är effektivt redundant i en sådan situation."
          },
          "at0014.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "Status",
            "description" : "Försiktighetsåtgärdens nuvarande status.",
            "comment" : "Beslutsstöd bör meddela varningar för 'Aktiv' och ignorera 'Upphört' eller 'Avfärdad'. Kliniska system kan välja att inte visa anteckningar om försiktighetsåtgärder med statusen 'Avfärdad' i en lista med försiktighetsåtgärder. Emellertid kan 'Avfärdad' vara användbar vid sammanställning av listor med försiktighetsåtgärder eller vid kommunikation mellan system. Några system kan välja att göra detta element till obligatoriskt. 'Upphört' kan användas olika över olika system beroende på klinisk användning och kontext. Fritextdatatypen tillåter lokal variation, vilket gör att andra värdesatser kan användas i det här dataelementet i en template. Vid sådana situationer rekommenderas att värden kodas med hjälp av en terminologi."
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "Belägg",
            "description" : "Beskrivning av de belägg som identifierats vilka stödjer försiktighetsåtgärden.",
            "comment" : "Det här data elementet kan valfritt länkas till en diagnos, testresultat, läkemedelsordination etc via ett URI (enligt Referensmodellen) i syfte att förse den logiska grunden eller bevisen för den påstådda försiktighetsåtgärden. Vänligen notera: eftersom den här URI-länken kanske inte är tillgänglig från ett meddelande eller att kliniska system inte kan ta emot den är det önskvärt att en berättande beskrivning görs av fynden samt att de blir tydligt dokumenterade."
          },
          "at0024.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "Giltlig slutperiod",
            "description" : "Datum eller tid från vilket tillståndet anses vara inaktivt.",
            "comment" : "Det här dataelementet syftar till att användas när en försiktighetsåtgärd har ett definitivt slutdatum eller tid någon gång i framtiden. Exempelvis det datum då en läkemedelsprövning upphör."
          },
          "at0004.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "Senast uppdaterad",
            "description" : "Datum då informationen om försiktighetsåtgärden senast uppdaterades."
          },
          "at0008.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "Kommentar",
            "description" : "Ytterligare beskrivning av försiktighetsåtgärden som inte fångas i några andra fält."
          },
          "at0009.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "Granskningsdatum",
            "description" : "Lämpligt datum för nästa granskning av en kliniker.",
            "comment" : "Vid omständigheter där försiktighetsåtgärden inte är definitiv eller livslång, använd då det här dataelementet för att dokumentera datum eller tid när försiktighetsåtgärden bör omvärderas i förhållande till den kliniska kontexten för det aktuella tillfället."
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "Försiktighetsåtgärd",
            "description" : "Ett tillstånd eller status hos en individ som är kliniskt signifikant och unik eller idiosynkratisk för den här individen och anses vara vital information i samband med beslut om behandling."
          },
          "at0022.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "Giltlig startperiod",
            "description" : "Datum eller tid från vilket tillståndet anses vara aktivt.",
            "comment" : "Det här dataelementet syftar till att användas när en försiktighetsåtgärd beräknas starta någon gång i framtiden. Exempelvis det inledande datumet för en läkemedelsprövning."
          }
        },
        "de" : {
          "at0002.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002.1",
            "text" : "Infektionsrisiken",
            "description" : "*Identification, by name, of a condition or state. (en)",
            "comment" : "*Coding of the identified 'Condition' with a terminology is desirable, where possible. (en)"
          },
          "ac0.1" : {
            "@type" : "ARCHETYPE_TERM",
            "text" : "*(Synthesized) (en)",
            "code" : "ac0.1",
            "description" : ""
          },
          "at0000" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "*Precaution (en)",
            "description" : "*A condition or state of the individual that is clinically significant and unique or idiosyncratic for this individual, and is considered vital information when making treatment decisions. (en)"
          },
          "at0001" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0001",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0002" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0002",
            "text" : "*Condition (en)",
            "description" : "*Identification, by name, of a condition or state. (en)",
            "comment" : "*Coding of the identified 'Condition' with a terminology is desirable, where possible. (en)"
          },
          "at0003" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "*Evidence (en)",
            "description" : "*Description of the evidence identified to support the precaution. (en)",
            "comment" : "*This data element can be optionally linked to a diagnosis, test result, medication order etc via a URI (as per the Reference Model) in order to provide the rationale or evidence for the precaution assertion. Please note: as this URI link may not be accessible from a message or by receiving clinical system it is desirable that a narrative description of the evidence should also be explicitly recorded. (en)"
          },
          "at0004" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "*Last updated (en)",
            "description" : "*Date when the precaution information was last updated. (en)"
          },
          "at0006" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0006",
            "text" : "Tree",
            "description" : "@ internal @"
          },
          "at0008" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "*Comment (en)",
            "description" : "*Additional narrative about the precaution, not captured in other fields. (en)"
          },
          "at0009" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "*Review date (en)",
            "description" : "*Date when next due for review by a clinician. (en)",
            "comment" : "*In circumstances where precautions are not indefinite or life-long, use this data element to record the date/time when this precaution should be reassessed in the context of the clinical circumstances at the time. (en)"
          },
          "at0013" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "*Category (en)",
            "description" : "*Type of the 'Condition' identified. (en)",
            "comment" : "*This data element has been included because it is currently being captured in some clinical systems. This information could be derived when terminology codes are used to represent the condition in clinical systems, and is effectively redundant in that situation. (en)"
          },
          "at0014" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "*Status (en)",
            "description" : "*Assertion about the current state of the identified 'Precaution'. (en)",
            "comment" : "*Decision support would typically raise alerts for 'Active' and ignore a 'Resolved' or 'Refuted' precaution. Clinical systems may choose not to display Precaution entries with a 'Refuted' status in the Precaution list. However, 'Refuted' may be useful for reconciliation of the Precaution list or when communicating between systems. Some implementations may choose to make this field mandatory. 'Resolved' may be used variably across systems, depending on clinical use and context. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology. (en)"
          },
          "at0015" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0015",
            "text" : "*Active (en)",
            "description" : "*The precaution is currently active. (en)"
          },
          "at0018" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0018",
            "text" : "*Resolved (en)",
            "description" : "*The previously asserted precaution has been clinically reassessed and considered no longer to be an active risk. (en)"
          },
          "at0019" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0019",
            "text" : "*Refuted (en)",
            "description" : "*The precaution has been clinically reassessed or has been disproved with a high level of clinical certainty by testing. (en)"
          },
          "at0020" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0020",
            "text" : "*Extension (en)",
            "description" : "*Additional information required to capture local content or to align with other reference models/formalisms. (en)",
            "comment" : "*For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents. (en)"
          },
          "at0022" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "*Valid period start (en)",
            "description" : "*Date/time after which the 'Condition' is regarded as active. (en)",
            "comment" : "*This data element is intended for use when a precaution is identified to start at some time in the future. For example: the commencement date for a pharmaceutical trial. (en)"
          },
          "at0024" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "*Valid period end (en)",
            "description" : "*Date/time after which the 'Condition' is regarded as inactive. (en)",
            "comment" : "*This data element is intended for use when a precaution is known to have a definitive end date/time in the future. For example: the cessation date for a pharmaceutical trial. (en)"
          },
          "at0025" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0025",
            "text" : "*Additional details (en)",
            "description" : "*Additional structured details about the precaution. (en)",
            "comment" : "*For example: clinical evidence supporting the precaution. (en)"
          },
          "at0013.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0013",
            "text" : "*Category (en)",
            "description" : "*Type of the 'Condition' identified. (en)",
            "comment" : "*This data element has been included because it is currently being captured in some clinical systems. This information could be derived when terminology codes are used to represent the condition in clinical systems, and is effectively redundant in that situation. (en)"
          },
          "at0014.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0014",
            "text" : "*Status (en)",
            "description" : "*Assertion about the current state of the identified 'Precaution'. (en)",
            "comment" : "*Decision support would typically raise alerts for 'Active' and ignore a 'Resolved' or 'Refuted' precaution. Clinical systems may choose not to display Precaution entries with a 'Refuted' status in the Precaution list. However, 'Refuted' may be useful for reconciliation of the Precaution list or when communicating between systems. Some implementations may choose to make this field mandatory. 'Resolved' may be used variably across systems, depending on clinical use and context. The free text data type will allow for local variation by enabling other value sets to be applied to this data element in a template - in this situation it is recommended that values should be coded using a terminology. (en)"
          },
          "at0003.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0003",
            "text" : "*Evidence (en)",
            "description" : "*Description of the evidence identified to support the precaution. (en)",
            "comment" : "*This data element can be optionally linked to a diagnosis, test result, medication order etc via a URI (as per the Reference Model) in order to provide the rationale or evidence for the precaution assertion. Please note: as this URI link may not be accessible from a message or by receiving clinical system it is desirable that a narrative description of the evidence should also be explicitly recorded. (en)"
          },
          "at0024.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0024",
            "text" : "*Valid period end (en)",
            "description" : "*Date/time after which the 'Condition' is regarded as inactive. (en)",
            "comment" : "*This data element is intended for use when a precaution is known to have a definitive end date/time in the future. For example: the cessation date for a pharmaceutical trial. (en)"
          },
          "at0004.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0004",
            "text" : "*Last updated (en)",
            "description" : "*Date when the precaution information was last updated. (en)"
          },
          "at0008.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0008",
            "text" : "*Comment (en)",
            "description" : "*Additional narrative about the precaution, not captured in other fields. (en)"
          },
          "at0009.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0009",
            "text" : "*Review date (en)",
            "description" : "*Date when next due for review by a clinician. (en)",
            "comment" : "*In circumstances where precautions are not indefinite or life-long, use this data element to record the date/time when this precaution should be reassessed in the context of the clinical circumstances at the time. (en)"
          },
          "at0000.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0000",
            "text" : "*Precaution (en)",
            "description" : "*A condition or state of the individual that is clinically significant and unique or idiosyncratic for this individual, and is considered vital information when making treatment decisions. (en)"
          },
          "at0022.1" : {
            "@type" : "ARCHETYPE_TERM",
            "code" : "at0022",
            "text" : "*Valid period start (en)",
            "description" : "*Date/time after which the 'Condition' is regarded as active. (en)",
            "comment" : "*This data element is intended for use when a precaution is identified to start at some time in the future. For example: the commencement date for a pharmaceutical trial. (en)"
          }
        }
      },
      "termBindings" : { },
      "terminologyExtracts" : { },
      "valueSets" : {
        "ac0.1" : {
          "@type" : "VALUE_SET",
          "id" : "ac0.1",
          "members" : [ "at0015", "at0018", "at0019" ]
        }
      }
    },
    "adlVersion" : "1.4",
    "buildUid" : "504c8b10-ac7b-446d-8e1b-2efcc0d0828b",
    "rmName" : "openehr",
    "rmRelease" : "1.1.0",
    "generated" : true,
    "otherMetaData" : { },
    "originalLanguage" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "en"
    },
    "translations" : [ {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "de"
      },
      "author" : { },
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "sv"
      },
      "author" : {
        "name" : "Daniel Hall",
        "organisation" : "Region Östergötland",
        "email" : "daniel.hall@regionostergotland.se"
      },
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "es-ar"
      },
      "author" : {
        "name" : "Alan March",
        "organisation" : "Hospital Universitario Austral",
        "email" : "amarch@cas.austral.edu.ar"
      },
      "accreditation" : "MD",
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "nb"
      },
      "author" : {
        "name" : "Silje Ljosland Bakke og John Tore Valand",
        "organisation" : "Helse Vest IKT",
        "email" : "silje.ljosland.bakke@helse-vest-ikt.no, john.tore.valand@helse-vest-ikt.no"
      },
      "otherDetails" : { }
    }, {
      "@type" : "TRANSLATION_DETAILS",
      "language" : {
        "terminologyId" : {
          "value" : "ISO_639-1"
        },
        "codeString" : "pt-br"
      },
      "author" : {
        "name" : "Débora Farage, Fernanda Maia, Laíse Figueiredo",
        "organisation" : "Core Consulting",
        "email" : "contato@coreconsulting.com.br"
      },
      "accreditation" : "Hospital Alemão Oswaldo Cruz (HAOC)",
      "otherDetails" : { }
    } ]
  } ],
  "originalLanguage" : {
    "terminologyId" : {
      "value" : "ISO_639-1"
    },
    "codeString" : "en"
  },
  "translations" : [ {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "de"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "fi"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "sv"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "es-ar"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "nb"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "ko"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "pt-br"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "sl"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "ar-sy"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "it"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "nl"
    },
    "author" : { },
    "otherDetails" : { }
  }, {
    "@type" : "TRANSLATION_DETAILS",
    "language" : {
      "terminologyId" : {
        "value" : "ISO_639-1"
      },
      "codeString" : "zh"
    },
    "author" : { },
    "otherDetails" : { }
  } ]
}